☰

Daniel C. Javitt - Publications

Affiliations: 
The Nathan S. Kline Institute, Orangeburg, NY, United States 
Area:
Cognitive Neuroscience and Schizophrenia
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

390/472 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Martínez A, Gaspar PA, Bermudez DH, Belen Aburto-Ponce M, Beggel O, Javitt DC. Disrupted third visual pathway function in schizophrenia: Evidence from real and implied motion processing. Neuroimage. Clinical. 41: 103570. PMID 38309185 DOI: 10.1016/j.nicl.2024.103570  0.539
2023 Sehatpour P, Kreither J, Lopez-Calderon J, Shastry AM, De Baun HM, Martinez A, Javitt DC. Network-level mechanisms underlying effects of transcranial direct current stimulation (tDCS) on visuomotor learning in schizophrenia. Translational Psychiatry. 13: 360. PMID 37993420 DOI: 10.1038/s41398-023-02656-3  0.466
2023 Martínez A, Gaspar PA, Bermudez DH, Aburto-Ponce MB, Javitt DC. Bottom-up and top-down contributions to impaired motion processing in schizophrenia. Medrxiv : the Preprint Server For Health Sciences. PMID 37461678 DOI: 10.1101/2023.07.07.23292259  0.797
2023 Javitt D, Sehatpour P, Kreither J, Lopez-Calderon J, Shastry A, De-Baun H, Martinez A. Network-level mechanisms underlying effects of transcranial direct current stimulation (tDCS) on visuomotor learning impairments in schizophrenia. Research Square. PMID 37066410 DOI: 10.21203/rs.3.rs-2711867/v1  0.495
2023 Javitt DC, Martinez A, Sehatpour P, Beloborodova A, Habeck C, Gazes Y, Bermudez D, Razlighi QR, Devanand DP, Stern Y. Disruption of early visual processing in amyloid-positive healthy individuals and mild cognitive impairment. Alzheimer's Research & Therapy. 15: 42. PMID 36855162 DOI: 10.1186/s13195-023-01189-7  0.426
2023 Dondé C, Kantrowitz JT, Medalia A, Saperstein AM, Balla A, Sehatpour P, Martinez A, O'Connell MN, Javitt DC. Early auditory processing dysfunction in schizophrenia: mechanisms and implications. Neuroscience and Biobehavioral Reviews. 105098. PMID 36796472 DOI: 10.1016/j.neubiorev.2023.105098  0.597
2022 Patel GH, Gruskin DC, Arkin SC, Jamerson EC, Ruiz-Betancourt DR, Klim CC, Sanchez-Peña JP, Bartel LP, Lee JK, Grinband J, Martinez A, Berman RA, Ochsner KN, Leopold DA, Javitt DC. The Road Not Taken: Disconnection of a Human-Unique Cortical Pathway Underlying Naturalistic Social Perception in Schizophrenia. Biological Psychiatry Global Open Science. 3: 398-408. PMID 37519457 DOI: 10.1016/j.bpsgos.2022.03.008  0.478
2022 Ho NF, Lin AY, Tng JXJ, Chew QH, Cheung MW, Javitt DC, Sim K. Abnormalities in visual cognition and associated impaired interactions between visual and attentional networks in schizophrenia and brief psychotic disorder. Psychiatry Research. Neuroimaging. 327: 111545. PMID 36272310 DOI: 10.1016/j.pscychresns.2022.111545  0.412
2022 Javitt DC. Cognitive Impairment Associated with Schizophrenia: Toward Novel Therapeutics. Annual Review of Pharmacology and Toxicology. PMID 36151052 DOI: 10.1146/annurev-pharmtox-051921-093250  0.387
2022 Adam O, Blay M, Brunoni AR, Chang HA, Gomes JS, Javitt DC, Jung DU, Kantrowitz JT, Koops S, Lindenmayer JP, Palm U, Smith RC, Sommer IE, Valiengo LDCL, Weickert TW, et al. Efficacy of Transcranial Direct Current Stimulation to Improve Insight in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Schizophrenia Bulletin. PMID 35820035 DOI: 10.1093/schbul/sbac078  0.371
2022 Martínez A, Tobe RH, Gaspar PA, Malinsky D, Dias EC, Sehatpour P, Lakatos P, Patel GH, Bermudez DH, Silipo G, Javitt DC. Disease-Specific Contribution of Pulvinar Dysfunction to Impaired Emotion Recognition in Schizophrenia. Frontiers in Behavioral Neuroscience. 15: 787383. PMID 35237135 DOI: 10.3389/fnbeh.2021.787383  0.806
2022 Hoptman MJ, Tural U, Lim KO, Javitt DC, Oberlin LE. Relationships between Diffusion Tensor Imaging and Resting State Functional Connectivity in Patients with Schizophrenia and Healthy Controls: A Preliminary Study. Brain Sciences. 12. PMID 35203920 DOI: 10.3390/brainsci12020156  0.664
2022 Javitt DC, Kantrowitz JT. The glutamate/N-methyl-d-aspartate receptor (NMDAR) model of schizophrenia at 35: On the path from syndrome to disease. Schizophrenia Research. PMID 35125283 DOI: 10.1016/j.schres.2022.01.013  0.327
2021 Patel GH, Arkin SC, Ruiz-Betancourt D, Plaza FI, Mirza SA, Vieira DJ, Strauss NE, Klim CC, Sanchez-Peña JP, Bartel LP, Grinband J, Martinez A, Berman RA, Ochsner KN, Leopold DA, ... Javitt DC, et al. Failure to engage the temporoparietal junction/posterior superior temporal sulcus predicts impaired naturalistic social cognition in schizophrenia. Brain : a Journal of Neurology. PMID 33710282 DOI: 10.1093/brain/awab081  0.552
2020 Balla A, Ginsberg SD, Abbas AI, Sershen H, Javitt DC. Translational neurophysiological biomarkers of N-methyl-d-aspartate receptor dysfunction in serine racemase knockout mice. Biomarkers in Neuropsychiatry. 2. PMID 34308374 DOI: 10.1016/j.bionps.2020.100019  0.74
2020 Sehatpour P, Avissar M, Kantrowitz JT, Corcoran CM, De Baun HM, Patel GH, Girgis RR, Brucato G, Lopez-Calderon J, Silipo G, Dias E, Martinez A, Javitt DC. Deficits in Pre-attentive Processing of Spatial Location and Negative Symptoms in Subjects at Clinical High Risk for Schizophrenia. Frontiers in Psychiatry. 11: 629144. PMID 33603682 DOI: 10.3389/fpsyt.2020.629144  0.61
2020 Sehatpour P, Bassir Nia A, Adair D, Wang Z, DeBaun HM, Silipo G, Martinez A, Javitt DC. Multimodal Computational Modeling of Visual Object Recognition Deficits but Intact Repetition Priming in Schizophrenia. Frontiers in Psychiatry. 11: 547189. PMID 33329086 DOI: 10.3389/fpsyt.2020.547189  0.595
2020 Sehatpour P, Donde C, Hoptman MJ, Kreither J, Adair D, Dias E, Vail B, Rohrig S, Silipo G, Lopez-Calderon J, Martinez A, Javitt DC. Network-level mechanisms underlying effects of transcranial direct current stimulation (tDCS) on visuomotor learning. Neuroimage. 117311. PMID 32889116 DOI: 10.1016/J.Neuroimage.2020.117311  0.665
2020 Dias EC, Sheridan H, Martínez A, Sehatpour P, Silipo G, Rohrig S, Hochman A, Butler PD, Hoptman MJ, Revheim N, Javitt DC. Neurophysiological, Oculomotor, and Computational Modeling of Impaired Reading Ability in Schizophrenia. Schizophrenia Bulletin. PMID 32851415 DOI: 10.1093/Schbul/Sbaa107  0.735
2020 Moreno-Ortega M, Kangarlu A, Lee S, Perera T, Kangarlu J, Palomo T, Glasser MF, Javitt DC. Parcel-guided rTMS for depression. Translational Psychiatry. 10: 283. PMID 32788580 DOI: 10.1038/S41398-020-00970-8  0.331
2020 Arkin SC, Ruiz-Betancourt D, Jamerson EC, Smith RT, Strauss NE, Klim CC, Javitt DC, Patel GH. Deficits and compensation: Attentional control cortical networks in schizophrenia. Neuroimage. Clinical. 27: 102348. PMID 32736323 DOI: 10.1016/J.Nicl.2020.102348  0.475
2020 Patel GH, Arkin SC, Ruiz-Betancourt DR, DeBaun HM, Strauss NE, Bartel LP, Grinband J, Martinez A, Berman RA, Leopold DA, Javitt DC. What you see is what you get: visual scanning failures of naturalistic social scenes in schizophrenia. Psychological Medicine. 1-10. PMID 32498743 DOI: 10.1017/S0033291720001646  0.561
2020 Kantrowitz JT, Grinband J, Goff DC, Lahti AC, Marder SR, Kegeles LS, Girgis RR, Sobeih T, Wall MM, Choo TH, Green MF, Yang YS, Lee J, Horga G, Krystal JH, ... ... Javitt DC, et al. Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32403118 DOI: 10.1038/S41386-020-0706-Z  0.347
2020 Javitt DC, Siegel SJ, Spencer KM, Mathalon DH, Hong LE, Martinez A, Ehlers CL, Abbas AI, Teichert T, Lakatos P, Womelsdorf T. A roadmap for development of neuro-oscillations as translational biomarkers for treatment development in neuropsychopharmacology. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32375159 DOI: 10.1038/S41386-020-0697-9  0.751
2020 Qian N, Lipkin RM, Kaszowska A, Silipo G, Dias EC, Butler PD, Javitt DC. Computational modeling of excitatory/inhibitory balance impairments in schizophrenia. Schizophrenia Research. PMID 32291128 DOI: 10.1016/j.schres.2020.03.027  0.494
2020 Dias EC, Van Voorhis AC, Braga F, Todd J, Lopez-Calderon J, Martinez A, Javitt DC. Impaired Fixation-Related Theta Modulation Predicts Reduced Visual Span and Guided Search Deficits in Schizophrenia. Cerebral Cortex (New York, N.Y. : 1991). PMID 32030407 DOI: 10.1093/cercor/bhz277  0.632
2020 Kantrowitz JT, Javitt DC, Freedman R, Sehatpour P, Kegeles LS, Carlson M, Sobeih T, Wall MM, Choo TH, Vail B, Grinband J, Lieberman JA. Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32015461 DOI: 10.1038/S41386-020-0628-9  0.443
2020 Kraus MS, Gold JM, Barch DM, Walker TM, Chun CA, Buchanan RW, Csernansky JG, Goff DC, Green MF, Jarskog LF, Javitt DC, Kimhy D, Lieberman JA, McEvoy JP, Mesholam-Gately RI, et al. The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measures. Schizophrenia Research. Cognition. 19: 100161. PMID 31832342 DOI: 10.1016/J.Scog.2019.100161  0.379
2020 Hoptman M, Javitt D. A Mediation Reanalysis of Pathways From Frontal Dysfunction to Aggression: The Role of Emotional Impulsivity Biological Psychiatry. 87: S356. DOI: 10.1016/j.biopsych.2020.02.913  0.58
2020 Avissar M, Vail B, Sehatpour P, Patel G, Javitt D. The Neural Circuitry of Delta Entrainment Deficits in Schizophrenia and its Implications Biological Psychiatry. 87: S233-S234. DOI: 10.1016/J.Biopsych.2020.02.606  0.498
2019 Lakatos P, O'Connell MN, Barczak A, McGinnis T, Neymotin S, Schroeder CE, Smiley JF, Javitt DC. The Thalamocortical Circuit of Auditory Mismatch Negativity. Biological Psychiatry. PMID 31924325 DOI: 10.1016/J.Biopsych.2019.10.029  0.371
2019 Dondé C, Martinez A, Sehatpour P, Patel GH, Kraut R, Kantrowitz JT, Javitt DC. Neural and functional correlates of impaired reading ability in schizophrenia. Scientific Reports. 9: 16022. PMID 31690846 DOI: 10.1038/S41598-019-52669-6  0.608
2019 Dondé C, Martínez A, Kantrowitz JT, Silipo G, Dias EC, Patel GH, Sanchez-Peña J, Corcoran CM, Medalia A, Saperstein A, Vail B, Javitt DC. Bimodal distribution of tone-matching deficits indicates discrete pathophysiological entities within the syndrome of schizophrenia. Translational Psychiatry. 9: 221. PMID 31492832 DOI: 10.1038/S41398-019-0557-8  0.618
2019 Martínez A, Tobe R, Dias EC, Ardekani BA, Veenstra-VanderWeele J, Patel G, Breland M, Lieval A, Silipo G, Javitt DC. Differential Patterns of Visual Sensory Alteration Underlying Face Emotion Recognition Impairment and Motion Perception Deficits in Schizophrenia and Autism Spectrum Disorder. Biological Psychiatry. PMID 31301757 DOI: 10.1016/J.Biopsych.2019.05.016  0.614
2019 Dondé C, Mondino M, Leitman DI, Javitt DC, Suaud-Chagny MF, D'Amato T, Brunelin J, Haesebaert F. Are basic auditory processes involved in source-monitoring deficits in patients with schizophrenia? Schizophrenia Research. PMID 31176535 DOI: 10.1016/j.schres.2019.05.034  0.778
2019 Dondé C, Avissar M, Weber MM, Javitt DC. A century of sensory processing dysfunction in schizophrenia. European Psychiatry : the Journal of the Association of European Psychiatrists. 59: 77-79. PMID 31082567 DOI: 10.1016/j.eurpsy.2019.04.006  0.497
2019 Kantrowitz JT, Sehatpour P, Avissar M, Horga G, Gwak A, Hoptman MJ, Beggel O, Girgis RR, Vail B, Silipo G, Carlson M, Javitt DC. Significant improvement in treatment resistant auditory verbal hallucinations after 5 days of double-blind, randomized, sham controlled, fronto-temporal, transcranial direct current stimulation (tDCS): A replication/extension study. Brain Stimulation. PMID 30922713 DOI: 10.1016/j.brs.2019.03.003  0.647
2019 Girgis RR, Baker S, Mao X, Gil R, Javitt DC, Kantrowitz JT, Gu M, Spielman DM, Ojeil N, Xu X, Abi-Dargham A, Shungu DC, Kegeles LS. Effects of acute N-acetylcysteine challenge on cortical glutathione and glutamate in schizophrenia: A pilot in vivo proton magnetic resonance spectroscopy study. Psychiatry Research. 275: 78-85. PMID 30884334 DOI: 10.1016/J.Psychres.2019.03.018  0.459
2019 Fleming LM, Javitt DC, Carter CS, Kantrowitz JT, Girgis RR, Kegeles LS, Ragland JD, Maddock RJ, Lesh TA, Tanase C, Robinson J, Potter WZ, Carlson M, Wall MM, Choo TH, et al. A multicenter study of ketamine effects on functional connectivity: Large scale network relationships, hubs and symptom mechanisms. Neuroimage. Clinical. 22: 101739. PMID 30852397 DOI: 10.1016/J.Nicl.2019.101739  0.497
2019 Medalia A, Saperstein AM, Qian M, Javitt DC. Impact of baseline early auditory processing on response to cognitive remediation for schizophrenia. Schizophrenia Research. PMID 30665714 DOI: 10.1016/j.schres.2019.01.012  0.429
2019 Martinez A, Tobe R, Breland M, Lieval A, Ardekani B, Javitt D. 39.2 MULTIMODAL INVESTIGATION OF CONVERGENT AND DIVERGENT PATTERNS OF ATYPICAL VISUAL PROCESSING UNDERLYING FACE EMOTION RECOGNITION AND MOTION PERCEPTION IN SCHIZOPHRENIA AND AUTISM Schizophrenia Bulletin. 45: S151-S152. DOI: 10.1093/SCHBUL/SBZ022.160  0.599
2019 Medalia A, Saperstein A, Qian M, Javitt D. 39.1 Baseline Early Auditory Processing As A Tailoring Variable To Personalize Cognitive Remediation For Schizophrenia Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz022.159  0.473
2019 Bilgrami Z, Benavides C, Sarac C, Shaik R, Keilp J, Gur R, Javitt D, Corcoran C. T35. SPEED OF FACE PROCESSING PREDICTS PSYCHOSIS IN AT-RISK YOUTHS Schizophrenia Bulletin. 45: S216-S217. DOI: 10.1093/Schbul/Sbz019.315  0.419
2019 Dondé C, Sehatpour P, Kreither J, Silipo G, Javitt DC. Comparison of high-definition and conventional tDCS on visuomotor sequence learning L'EncéPhale. 45: S82-S83. DOI: 10.1016/J.Encep.2019.04.048  0.338
2019 Patel G, Arkin S, Ruiz-Betancourt D, Jamerson E, Sanchez-Peña J, Javitt DC. F189. Deficits and Compensation in Attentional Networks in Schizophrenia Biological Psychiatry. 85: S286-S287. DOI: 10.1016/J.Biopsych.2019.03.726  0.429
2019 Lieberman J, Goff D, Marder S, Lahti A, Javitt D, Kantrowitz J, Girgis R, Grinband J, Kegeles L, Wall M, Chou T. 117. Biomarker Assessment of Dose Dependent Target Engagement of mGluR-2,3 Partial Agonist for Schizophrenia Treatment Biological Psychiatry. 85: S49. DOI: 10.1016/J.Biopsych.2019.03.131  0.407
2018 Dondé C, Silipo G, Dias EC, Javitt DC. Hierarchical deficits in auditory information processing in schizophrenia. Schizophrenia Research. PMID 30551982 DOI: 10.1016/j.schres.2018.12.001  0.512
2018 Martínez A, Gaspar PA, Hillyard SA, Andersen SK, Lopez-Calderon J, Corcoran CM, Javitt DC. Impaired Motion Processing in Schizophrenia and the Attenuated Psychosis Syndrome: Etiological and Clinical Implications. The American Journal of Psychiatry. appiajp201818010072. PMID 30278791 DOI: 10.1176/Appi.Ajp.2018.18010072  0.82
2018 Yuan A, Veeranna, Sershen H, Basavarajappa BS, Smiley JF, Hashim A, Bleiwas C, Berg M, Guifoyle DN, Subbanna S, Darji S, Kumar A, Rao MV, Wilson DA, Julien JP, ... Javitt DC, et al. Neurofilament light interaction with GluN1 modulates neurotransmission and schizophrenia-associated behaviors. Translational Psychiatry. 8: 167. PMID 30143609 DOI: 10.1038/S41398-018-0194-7  0.455
2018 Girgis RR, Zoghbi AW, Javitt DC, Lieberman JA. The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review. Journal of Psychiatric Research. PMID 30055853 DOI: 10.1016/J.Jpsychires.2018.07.006  0.41
2018 Hoptman MJ, Parker EM, Nair-Collins S, Dias EC, Ross ME, DiCostanzo JN, Sehatpour P, Javitt DC. Sensory and cross-network contributions to response inhibition in patients with schizophrenia. Neuroimage. Clinical. 18: 31-39. PMID 29868440 DOI: 10.1016/J.Nicl.2018.01.001  0.822
2018 Pobric G, Hulleman J, Lavidor M, Silipo G, Rohrig S, Dias E, Javitt DC. Seeing the World as it is: Mimicking Veridical Motion Perception in Schizophrenia Using Non-invasive Brain Stimulation in Healthy Participants. Brain Topography. PMID 29516204 DOI: 10.1007/s10548-018-0639-6  0.429
2018 Javitt DC. Excitatory Amino Acids in Schizophrenia: Both What You Have, and What You Do With Them. Biological Psychiatry. 83: 470-472. PMID 29429500 DOI: 10.1016/j.biopsych.2018.01.006  0.41
2018 Corcoran CM, Carrillo F, Fernández-Slezak D, Bedi G, Klim C, Javitt DC, Bearden CE, Cecchi GA. Prediction of psychosis across protocols and risk cohorts using automated language analysis. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 17: 67-75. PMID 29352548 DOI: 10.1002/Wps.20491  0.489
2018 Lieberman JA, Girgis RR, Brucato G, Moore H, Provenzano F, Kegeles L, Javitt D, Kantrowitz J, Wall MM, Corcoran CM, Schobel SA, Small SA. Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention. Molecular Psychiatry. PMID 29311665 DOI: 10.1038/Mp.2017.249  0.464
2018 Corcoran C, Grinband J, Gowatsky J, Klim C, Hoptman M, Javitt D. S21. EVENT-RELATED REPETITIVE TMS TO RIGHT POSTERIOR STS (BUT NOT OCCIPITAL FACE AREA) IN HEALTHY VOLUNTEERS (HV) BRIEFLY RECAPITULATES FACE EMOTION RECOGNITION (FER) DEFICITS OF SCHIZOPHRENIA (SZ) Schizophrenia Bulletin. 44: S331-S331. DOI: 10.1093/Schbul/Sby018.808  0.67
2018 Corcoran C, Carrillo F, Slezak DF, Klim C, Bedi G, Javitt D, Bearden C, Cecchi G. 26.4 LANGUAGE DISTURBANCE AS A PREDICTOR OF PSYCHOSIS ONSET IN YOUTH AT ENHANCED CLINICAL RISK Schizophrenia Bulletin. 44: S43-S44. DOI: 10.1093/Schbul/Sby014.109  0.503
2018 Van Voorhis A, Braga F, Javitt D, Dias E. T218. Reduced Amplitude of Fixation-Related Potentials Predicts Impaired Serial Search Performance in Schizophrenia Biological Psychiatry. 83: S213. DOI: 10.1016/j.biopsych.2018.02.555  0.445
2018 Dias E, Martinez A, Silipo G, Stoops A, Hochman A, Hoptman M, Revheim N, Javitt D. 104. Neural Basis of Reading Dysfunction in Schizophrenia Biological Psychiatry. 83: S43. DOI: 10.1016/j.biopsych.2018.02.122  0.752
2018 Lee M, Sehatpour P, Corcoran C, Kim T, Vail B, Javitt DC. S275. Failures of Oscillatory Entrainment in Individuals at Clinical High Risk for Schizophrenia Biological Psychiatry. 83: S455. DOI: 10.1016/j.biopsych.2018.02.1167  0.392
2018 Herrera S, Butler PD, Zemon V, Javitt DC, Hoptman MJ. S250. Associations Between Contrast Processes and Resting-State Functional Connectivity in Patients With Schizophrenia and Healthy Controls Biological Psychiatry. 83: S445. DOI: 10.1016/j.biopsych.2018.02.1142  0.691
2018 Corcoran C, Grinband J, Gowatsky J, Klim C, Hoptman M, Javitt D. S202. Event-Related Repetitive TMS to Right Posterior STS (but not OFA) in Healthy Volunteers (HV) Briefly Recapitulates Face Emotion Recognition (FER) Deficits of Schizophrenia Biological Psychiatry. 83: S426. DOI: 10.1016/j.biopsych.2018.02.1094  0.343
2017 Javitt DC, Carter CS, Krystal JH, Kantrowitz JT, Girgis RR, Kegeles LS, Ragland JD, Maddock RJ, Lesh TA, Tanase C, Corlett PR, Rothman DL, Mason G, Qiu M, Robinson J, et al. Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial. Jama Psychiatry. PMID 29167877 DOI: 10.1001/Jamapsychiatry.2017.3572  0.334
2017 Avissar M, Javitt D. Mismatch negativity: A simple and useful biomarker of N-methyl-d-aspartate receptor (NMDAR)-type glutamate dysfunction in schizophrenia. Schizophrenia Research. PMID 29132813 DOI: 10.1016/j.schres.2017.11.006  0.393
2017 Corcoran CM, Stoops A, Lee M, Martinez A, Sehatpour P, Dias EC, Javitt DC. Developmental trajectory of mismatch negativity and visual event-related potentials in healthy controls: Implications for neurodevelopmental vs. neurodegenerative models of schizophrenia. Schizophrenia Research. PMID 29033283 DOI: 10.1016/j.schres.2017.09.047  0.65
2017 Lee M, Balla A, Sershen H, Sehatpour P, Lakatos P, Javitt DC. Rodent Mismatch Negativity (MMN)/Theta Neuro-Oscillatory Response as a Translational Neurophysiological Biomarker for N-Methyl-D-Aspartate Receptor-Based New Treatment Development in Schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28816240 DOI: 10.1038/npp.2017.176  0.479
2017 Lee M, Sehatpour P, Dias EC, Silipo GS, Kantrowitz JT, Martinez AM, Javitt DC. A tale of two sites: Differential impairment of frequency and duration mismatch negativity across a primarily inpatient versus a primarily outpatient site in schizophrenia. Schizophrenia Research. PMID 28779851 DOI: 10.1016/j.schres.2017.07.032  0.617
2017 Avissar M, Xie S, Vail B, Lopez-Calderon J, Wang Y, Javitt DC. Meta-analysis of mismatch negativity to simple versus complex deviants in schizophrenia. Schizophrenia Research. PMID 28709770 DOI: 10.1016/j.schres.2017.07.009  0.498
2017 Javitt DC, Lee M, Kantrowitz JT, Martinez A. Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia. Schizophrenia Research. PMID 28666633 DOI: 10.1016/j.schres.2017.06.023  0.622
2017 Kantrowitz JT, Nolan KA, Epstein ML, Lehrfeld N, Shope C, Petkova E, Javitt DC. Neurophysiological Effects of Bitopertin in Schizophrenia. Journal of Clinical Psychopharmacology. PMID 28590364 DOI: 10.1097/Jcp.0000000000000722  0.73
2017 Perrin MA, Kantrowitz JT, Silipo G, Dias E, Jabado O, Javitt DC. Mismatch negativity (MMN) to spatial deviants and behavioral spatial discrimination ability in the etiology of auditory verbal hallucinations and thought disorder in schizophrenia. Schizophrenia Research. PMID 28532686 DOI: 10.1016/J.Schres.2017.05.012  0.729
2017 Kantrowitz JT, Epstein ML, Lee M, Lehrfeld N, Nolan KA, Shope C, Petkova E, Silipo G, Javitt DC. Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms. Schizophrenia Research. PMID 28318835 DOI: 10.1016/J.Schres.2017.02.027  0.725
2017 Lee M, Sehatpour P, Hoptman MJ, Lakatos P, Dias EC, Kantrowitz JT, Martinez AM, Javitt DC. Neural mechanisms of mismatch negativity dysfunction in schizophrenia. Molecular Psychiatry. PMID 28167837 DOI: 10.1038/mp.2017.3  0.782
2017 Amiaz R, Kent I, Rubinstein K, Sela BA, Javitt D, Weiser M. Safety, tolerability and pharmacokinetics of open label sarcosine added on to anti-psychotic treatment in schizophrenia - preliminary study. The Israel Journal of Psychiatry and Related Sciences. 52: 12-5. PMID 25841105  0.332
2017 Sehatpour P, Kreither J, Adair D, Rohrig S, Javitt DC. Improving Motor Function in Schizophrenia with Transcranial Direct Current Stimulation Brain Stimulation. 10: e25. DOI: 10.1016/J.Brs.2017.04.020  0.396
2017 Corcoran C, Grinband J, Gowatsky J, Klim C, Hoptman M, Javitt D. Event-related repetitive TMS to right posterior STS (but not OFA) in healthy volunteers (HV) briefly recapitulates face emotion recognition (FER) deficits of schizophrenia Brain Stimulation. 10: e44-e45. DOI: 10.1016/J.Biopsych.2018.02.1094  0.683
2017 Kantrowitz J, Epstein M, Beggel O, Rohrig S, Lehrfeld J, Revheim N, Lehrfeld N, Reep J, Parker E, Silipo G, Ahissar M, Javitt D. 428. Neurophysiological Mechanisms of Cortical Learning Plasticity Impairments in Schizophrenia and Modulation by the N-Methyl-D-Aspartate Type Glutamate Receptor Agonist D-Serine Biological Psychiatry. 81: S174-S175. DOI: 10.1016/J.Biopsych.2017.02.912  0.695
2017 Patel G, Arkin S, Klim C, Lopez-Calderon J, Martinez A, Berman R, Leopold D, Javitt D. 541. Deficits in and Compensation for Engagement of Social Cognition Areas in Schizophrenia during Naturalistic Viewing Biological Psychiatry. 81: S219. DOI: 10.1016/J.Biopsych.2017.02.1149  0.596
2016 Kantrowitz JT, Epstein ML, Beggel O, Rohrig S, Lehrfeld JM, Revheim N, Lehrfeld NP, Reep J, Parker E, Silipo G, Ahissar M, Javitt DC. Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine. Brain : a Journal of Neurology. 139: 3281-3295. PMID 27913408 DOI: 10.1093/Brain/Aww262  0.837
2016 Javitt DC. Bitopertin in schizophrenia: glass half full? The Lancet. Psychiatry. PMID 27816569 DOI: 10.1016/S2215-0366(16)30354-6  0.459
2016 Trémeau F, Antonius D, Malaspina D, Goff DC, Javitt DC. Loneliness in schizophrenia and its possible correlates. An exploratory study. Psychiatry Research. 246: 211-217. PMID 27721059 DOI: 10.1016/J.Psychres.2016.09.043  0.43
2016 Lakatos P, Barczak A, Neymotin SA, McGinnis T, Ross D, Javitt DC, O'Connell MN. Global dynamics of selective attention and its lapses in primary auditory cortex. Nature Neuroscience. 19: 1707-1717. PMID 27618311 DOI: 10.1038/Nn.4386  0.342
2016 Choi J, Corcoran CM, Fiszdon JM, Stevens M, Javitt DC, Deasy M, Haber LC, Dewberry MJ, Pearlson GD. Pupillometer-Based Neurofeedback Cognitive Training to Improve Processing Speed and Social Functioning in Individuals at Clinical High Risk for Psychosis. Psychiatric Rehabilitation Journal. PMID 27560455 DOI: 10.1037/prj0000217  0.35
2016 Beck K, Javitt DC, Howes OD. Targeting glutamate to treat schizophrenia: lessons from recent clinical studies. Psychopharmacology. PMID 27212398 DOI: 10.1007/s00213-016-4318-6  0.422
2016 Zhao G, Denisova K, Sehatpour P, Long J, Gui W, Qiao J, Javitt DC, Wang Z. Fractal Dimension Analysis of Subcortical Gray Matter Structures in Schizophrenia. Plos One. 11: e0155415. PMID 27176232 DOI: 10.1371/journal.pone.0155415  0.464
2016 Tobe RH, Corcoran CM, Breland M, MacKay-Brandt A, Klim C, Colcombe SJ, Leventhal BL, Javitt DC. Differential profiles in auditory social cognition deficits between adults with autism and schizophrenia spectrum disorders: A preliminary analysis. Journal of Psychiatric Research. 79: 21-27. PMID 27131617 DOI: 10.1016/j.jpsychires.2016.04.005  0.442
2016 Trémeau F, Antonius D, Todorov A, Rebani Y, Ferrari K, Lee SH, Calderone D, Nolan KA, Butler P, Malaspina D, Javitt DC. What can the study of first impressions tell us about attitudinal ambivalence and paranoia in schizophrenia? Psychiatry Research. 238: 86-92. PMID 27086216 DOI: 10.1016/J.Psychres.2016.02.014  0.411
2016 Javitt DC. Biotypes in Psychosis: Has the RDoC Era Arrived? The American Journal of Psychiatry. 173: 313-4. PMID 27035527 DOI: 10.1176/appi.ajp.2016.16020140  0.445
2016 Amiaz R, Vainiger D, Gershon AA, Weiser M, Lavidor M, Javitt DC. Applying Transcranial Magnetic Stimulation (TMS) Over the Dorsal Visual Pathway Induces Schizophrenia-like Disruption of Perceptual Closure. Brain Topography. PMID 27021230 DOI: 10.1007/s10548-016-0487-1  0.526
2016 Sershen H, Hashim A, Dunlop DS, Suckow RF, Cooper TB, Javitt DC. Modulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model. Neurochemical Research. PMID 26857796 DOI: 10.1007/s11064-016-1838-8  0.309
2016 Pobric G, Hulleman J, Lavidor M, Javitt D. Seeing the world as it is: veridical motion perception in schizophrenia and effects of non-invasive transcranial electric stimulation Journal of Vision. 16: 888-888. DOI: 10.1167/16.12.888  0.394
2016 Trémeau F, Antonius D, Todorov A, Rebani Y, Ferrari K, Lee SH, Calderone D, Nolan KA, Butler P, Malaspina D, Javitt DC. What can the study of first impressions tell us about attitudinal ambivalence and paranoia in schizophrenia? Psychiatry Research. 238: 86-92. DOI: 10.1016/j.psychres.2016.02.014  0.376
2016 Lee M, Hoptman M, Sehatpour P, Lakatos P, Dias E, Kantrowitz J, Martinez A, Javitt D. Neural mechanisms of mismatch negativity (MMN) dysfunction in schizophrenia International Journal of Psychophysiology. 108: 37. DOI: 10.1016/J.IJPSYCHO.2016.07.123  0.627
2015 Javitt DC. Meeting overview: Sensory perception and schizophrenia, Lausanne, Switzerland June 31-July 1, 2014. Schizophrenia Research. Cognition. 2: 42-45. PMID 29114453 DOI: 10.1016/j.scog.2015.04.003  0.534
2015 van Atteveldt N, Musacchia G, Zion-Golumbic E, Sehatpour P, Javitt DC, Schroeder C. Complementary fMRI and EEG evidence for more efficient neural processing of rhythmic vs. unpredictably timed sounds. Frontiers in Psychology. 6: 1663. PMID 26579044 DOI: 10.3389/Fpsyg.2015.01663  0.36
2015 Kantrowitz JT, Hoptman MJ, Leitman DI, Moreno-Ortega M, Lehrfeld JM, Dias E, Sehatpour P, Laukka P, Silipo G, Javitt DC. Neural Substrates of Auditory Emotion Recognition Deficits in Schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 14909-21. PMID 26538659 DOI: 10.1523/Jneurosci.4603-14.2015  0.843
2015 Trémeau F, Antonius D, Todorov A, Rebani Y, Ferrari K, Lee SH, Calderone D, Nolan KA, Butler P, Malaspina D, Javitt DC. Implicit emotion perception in schizophrenia. Journal of Psychiatric Research. 71: 112-119. PMID 26473695 DOI: 10.1016/J.Jpsychires.2015.10.001  0.397
2015 Kantrowitz JT, Woods SW, Petkova E, Cornblatt B, Corcoran CM, Chen H, Silipo G, Javitt DC. D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial. The Lancet. Psychiatry. 2: 403-12. PMID 26360284 DOI: 10.1016/S2215-0366(15)00098-X  0.438
2015 Javitt DC. Current and emergent treatments for symptoms and neurocognitive impairment in schizophrenia. Current Treatment Options in Psychiatry. 1: 107-120. PMID 26301175 DOI: 10.1007/s40501-014-0010-9  0.431
2015 Javitt DC, Sweet RA. Auditory dysfunction in schizophrenia: integrating clinical and basic features. Nature Reviews. Neuroscience. 16: 535-50. PMID 26289573 DOI: 10.1038/nrn4002  0.525
2015 Martínez A, Gaspar PA, Hillyard SA, Bickel S, Lakatos P, Dias EC, Javitt DC. Neural oscillatory deficits in schizophrenia predict behavioral and neurocognitive impairments. Frontiers in Human Neuroscience. 9: 371. PMID 26190988 DOI: 10.3389/Fnhum.2015.00371  0.821
2015 Corcoran CM, Keilp JG, Kayser J, Klim C, Butler PD, Bruder GE, Gur RC, Javitt DC. Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective. Psychological Medicine. 45: 2959-73. PMID 26040537 DOI: 10.1017/S0033291715000902  0.597
2015 Carrión RE, Cornblatt BA, McLaughlin D, Chang J, Auther AM, Olsen RH, Javitt DC. Contributions of early cortical processing and reading ability to functional status in individuals at clinical high risk for psychosis. Schizophrenia Research. 164: 1-7. PMID 25728833 DOI: 10.1016/j.schres.2015.01.030  0.422
2015 Javitt DC. Neurophysiological models for new treatment development in schizophrenia: early sensory approaches. Annals of the New York Academy of Sciences. 1344: 92-104. PMID 25721890 DOI: 10.1111/nyas.12689  0.524
2015 Levin R, Dor-Abarbanel AE, Edelman S, Durrant AR, Hashimoto K, Javitt DC, Heresco-Levy U. Behavioral and cognitive effects of the N-methyl-D-aspartate receptor co-agonist D-serine in healthy humans: initial findings. Journal of Psychiatric Research. 61: 188-95. PMID 25554623 DOI: 10.1016/j.jpsychires.2014.12.007  0.336
2015 Javitt DC, Freedman R. Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia. The American Journal of Psychiatry. 172: 17-31. PMID 25553496 DOI: 10.1176/Appi.Ajp.2014.13121691  0.423
2015 Heresco-Levy U, Durrant AR, Ermilov M, Javitt DC, Miya K, Mori H. Clinical and electrophysiological effects of D-serine in a schizophrenia patient positive for anti-N-methyl-D-aspartate receptor antibodies. Biological Psychiatry. 77: e27-9. PMID 25442007 DOI: 10.1016/j.biopsych.2014.08.023  0.36
2015 Corcoran CM, Keilp JG, Kayser J, Klim C, Butler PD, Bruder GE, Gur RC, Javitt DC. Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective Psychological Medicine. DOI: 10.1017/S0033291715000902  0.486
2015 Javitt DC. Meeting overview: Sensory perception and schizophrenia, Lausanne, Switzerland June 31-July 1, 2014 Schizophrenia Research: Cognition. 2: 42-45. DOI: 10.1016/j.scog.2015.04.003  0.395
2014 Petkova E, Lu F, Kantrowitz J, Sanchez JL, Lehrfeld J, Scaramello N, Silipo G, DiCostanza J, Ross M, Su Z, Javitt DC, Butler PD. Auditory tasks for assessment of sensory function and affective prosody in schizophrenia. Comprehensive Psychiatry. 55: 1862-74. PMID 25214372 DOI: 10.1016/J.Comppsych.2014.08.046  0.485
2014 Revheim N, Corcoran CM, Dias E, Hellmann E, Martinez A, Butler PD, Lehrfeld JM, DiCostanzo J, Albert J, Javitt DC. Reading deficits in schizophrenia and individuals at high clinical risk: relationship to sensory function, course of illness, and psychosocial outcome. The American Journal of Psychiatry. 171: 949-59. PMID 25178752 DOI: 10.1176/appi.ajp.2014.13091196  0.628
2014 Trémeau F, Antonius D, Nolan K, Butler P, Javitt DC. Immediate affective motivation is not impaired in schizophrenia. Schizophrenia Research. 159: 157-63. PMID 25159096 DOI: 10.1016/J.Schres.2014.08.001  0.415
2014 Hoptman MJ, Antonius D, Mauro CJ, Parker EM, Javitt DC. Cortical thinning, functional connectivity, and mood-related impulsivity in schizophrenia: relationship to aggressive attitudes and behavior. The American Journal of Psychiatry. 171: 939-48. PMID 25073506 DOI: 10.1176/Appi.Ajp.2014.13111553  0.796
2014 Kantrowitz JT, Scaramello N, Jakubovitz A, Lehrfeld JM, Laukka P, Elfenbein HA, Silipo G, Javitt DC. Amusia and protolanguage impairments in schizophrenia. Psychological Medicine. 44: 2739-48. PMID 25066878 DOI: 10.1017/S0033291714000373  0.478
2014 Javitt DC. Distress intolerance, kynurenic acid, and schizophrenia. Jama Psychiatry. 71: 749-50. PMID 24806109 DOI: 10.1001/jamapsychiatry.2014.518  0.335
2014 Brunoni AR, Shiozawa P, Truong D, Javitt DC, Elkis H, Fregni F, Bikson M. Understanding tDCS effects in schizophrenia: a systematic review of clinical data and an integrated computation modeling analysis. Expert Review of Medical Devices. 11: 383-94. PMID 24754366 DOI: 10.1586/17434440.2014.911082  0.469
2014 Poels EM, Kegeles LS, Kantrowitz JT, Javitt DC, Lieberman JA, Abi-Dargham A, Girgis RR. Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings. Schizophrenia Research. 152: 325-32. PMID 24418122 DOI: 10.1016/J.Schres.2013.12.013  0.371
2014 Poels EM, Kegeles LS, Kantrowitz JT, Slifstein M, Javitt DC, Lieberman JA, Abi-Dargham A, Girgis RR. Imaging glutamate in schizophrenia: review of findings and implications for drug discovery. Molecular Psychiatry. 19: 20-9. PMID 24166406 DOI: 10.1038/mp.2013.136  0.327
2014 Kantrowitz JT, Hoptman MJ, Leitman DI, Silipo G, Javitt DC. The 5% difference: early sensory processing predicts sarcasm perception in schizophrenia and schizo-affective disorder. Psychological Medicine. 44: 25-36. PMID 23611263 DOI: 10.1017/S0033291713000834  0.842
2014 Hoptman MJ, Parker EM, Rohrig S, Sanchez JL, Javitt DC. Transcranial Direct Current Stimulation Effects on Time/Frequency Relationships in Patients with Schizophrenia Brain Stimulation. 7: e7-e8. DOI: 10.1016/J.Brs.2014.01.029  0.789
2014 Sehatpour P, Adair D, Rohrig S, Kaszowska A, David A, Epstein M, Di Costanzo J, Javitt DC. Cortical Modulation using Transcranial Direct Current Stimulation. Brain Stimulation. 7: e4. DOI: 10.1016/J.Brs.2014.01.017  0.598
2013 Smiley JF, Hackett TA, Preuss TM, Bleiwas C, Figarsky K, Mann JJ, Rosoklija G, Javitt DC, Dwork AJ. Hemispheric asymmetry of primary auditory cortex and Heschl's gyrus in schizophrenia and nonpsychiatric brains. Psychiatry Research. 214: 435-43. PMID 24148910 DOI: 10.1016/J.Pscychresns.2013.08.009  0.392
2013 Ermilov M, Gelfin E, Levin R, Lichtenberg P, Hashimoto K, Javitt DC, Heresco-Levy U. A pilot double-blind comparison of d-serine and high-dose olanzapine in treatment-resistant patients with schizophrenia. Schizophrenia Research. 150: 604-5. PMID 24094884 DOI: 10.1016/j.schres.2013.09.018  0.404
2013 Dias EC, Bickel S, Epstein ML, Sehatpour P, Javitt DC. Abnormal task modulation of oscillatory neural activity in schizophrenia. Frontiers in Psychology. 4: 540. PMID 23986729 DOI: 10.3389/fpsyg.2013.00540  0.726
2013 Spering M, Dias EC, Sanchez JL, Schütz AC, Javitt DC. Efference copy failure during smooth pursuit eye movements in schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 11779-87. PMID 23864667 DOI: 10.1523/JNEUROSCI.0578-13.2013  0.715
2013 Lakatos P, Schroeder CE, Leitman DI, Javitt DC. Predictive suppression of cortical excitability and its deficit in schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 11692-702. PMID 23843536 DOI: 10.1523/Jneurosci.0010-13.2013  0.763
2013 Trémeau F, Goldman J, Antonius D, Javitt DC. Inpatients with schizophrenia report impaired situational motivation but intact global and social motivation. Psychiatry Research. 210: 43-9. PMID 23796827 DOI: 10.1016/J.Psychres.2013.05.031  0.483
2013 Lakatos P, Musacchia G, O'Connel MN, Falchier AY, Javitt DC, Schroeder CE. The spectrotemporal filter mechanism of auditory selective attention. Neuron. 77: 750-61. PMID 23439126 DOI: 10.1016/J.Neuron.2012.11.034  0.308
2013 Heresco-Levy U, Shoham S, Javitt DC. Glycine site agonists of the N-methyl-D-aspartate receptor and Parkinson's disease: a hypothesis. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 419-24. PMID 23427107 DOI: 10.1002/mds.25306  0.312
2013 Guilfoyle DN, Gerum SV, Sanchez JL, Balla A, Sershen H, Javitt DC, Hoptman MJ. Functional connectivity fMRI in mouse brain at 7T using isoflurane. Journal of Neuroscience Methods. 214: 144-8. PMID 23376497 DOI: 10.1016/j.jneumeth.2013.01.019  0.573
2013 Jarskog LF, Dong Z, Kangarlu A, Colibazzi T, Girgis RR, Kegeles LS, Barch DM, Buchanan RW, Csernansky JG, Goff DC, Harms MP, Javitt DC, Keefe RS, McEvoy JP, McMahon RP, et al. Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1245-52. PMID 23325325 DOI: 10.1038/Npp.2013.23  0.467
2013 Calderone DJ, Martinez A, Zemon V, Hoptman MJ, Hu G, Watkins JE, Javitt DC, Butler PD. Comparison of psychophysical, electrophysiological, and fMRI assessment of visual contrast responses in patients with schizophrenia. Neuroimage. 67: 153-62. PMID 23194815 DOI: 10.1016/j.neuroimage.2012.11.019  0.765
2013 Woods SW, Walsh BC, Hawkins KA, Miller TJ, Saksa JR, D'Souza DC, Pearlson GD, Javitt DC, McGlashan TH, Krystal JH. Glycine treatment of the risk syndrome for psychosis: report of two pilot studies. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 931-40. PMID 23089076 DOI: 10.1016/J.Euroneuro.2012.09.008  0.336
2013 Calderone DJ, Hoptman MJ, Martínez A, Nair-Collins S, Mauro CJ, Bar M, Javitt DC, Butler PD. Contributions of low and high spatial frequency processing to impaired object recognition circuitry in schizophrenia. Cerebral Cortex (New York, N.Y. : 1991). 23: 1849-58. PMID 22735157 DOI: 10.1093/Cercor/Bhs169  0.801
2013 Kantrowitz JT, Leitman DI, Lehrfeld JM, Laukka P, Juslin PN, Butler PD, Silipo G, Javitt DC. Reduction in tonal discriminations predicts receptive emotion processing deficits in schizophrenia and schizoaffective disorder. Schizophrenia Bulletin. 39: 86-93. PMID 21725063 DOI: 10.1093/Schbul/Sbr060  0.775
2013 Calderone DJ, Martinez A, Zemon V, Hoptman MJ, Hu G, Watkins JE, Javitt DC, Butler PD. Corrigendum to "Comparison of psychophysical, electrophysiological, and fMRI assessment of visual contrast responses in patients with schizophrenia" [Neuroimage 67C (2013) 153-162] Neuroimage. 83: 1110. DOI: 10.1016/j.neuroimage.2013.07.059  0.749
2012 Martínez A, Revheim N, Butler PD, Guilfoyle DN, Dias EC, Javitt DC. Impaired magnocellular/dorsal stream activation predicts impaired reading ability in schizophrenia. Neuroimage. Clinical. 2: 8-16. PMID 24179753 DOI: 10.1016/j.nicl.2012.09.006  0.669
2012 Nooner KB, Colcombe SJ, Tobe RH, Mennes M, Benedict MM, Moreno AL, Panek LJ, Brown S, Zavitz ST, Li Q, Sikka S, Gutman D, Bangaru S, Schlachter RT, Kamiel SM, ... ... Javitt DC, et al. The NKI-Rockland Sample: A Model for Accelerating the Pace of Discovery Science in Psychiatry. Frontiers in Neuroscience. 6: 152. PMID 23087608 DOI: 10.3389/Fnins.2012.00152  0.557
2012 Javitt DC. Glycine transport inhibitors in the treatment of schizophrenia. Handbook of Experimental Pharmacology. 367-99. PMID 23027421 DOI: 10.1007/978-3-642-25758-2_12  0.409
2012 Javitt DC, Zukin SR, Heresco-Levy U, Umbricht D. Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia. Schizophrenia Bulletin. 38: 958-66. PMID 22987851 DOI: 10.1093/schbul/sbs069  0.528
2012 Javitt DC. Twenty-five years of glutamate in schizophrenia: are we there yet? Schizophrenia Bulletin. 38: 911-3. PMID 22987849 DOI: 10.1093/schbul/sbs100  0.477
2012 Hoptman MJ, Zuo XN, D'Angelo D, Mauro CJ, Butler PD, Milham MP, Javitt DC. Decreased interhemispheric coordination in schizophrenia: a resting state fMRI study. Schizophrenia Research. 141: 1-7. PMID 22910401 DOI: 10.1016/J.Schres.2012.07.027  0.705
2012 Weiser M, Heresco-Levy U, Davidson M, Javitt DC, Werbeloff N, Gershon AA, Abramovich Y, Amital D, Doron A, Konas S, Levkovitz Y, Liba D, Teitelbaum A, Mashiach M, Zimmerman Y. A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia. The Journal of Clinical Psychiatry. 73: e728-34. PMID 22795211 DOI: 10.4088/JCP.11m07031  0.405
2012 Bickel S, Dias EC, Epstein ML, Javitt DC. Expectancy-related modulations of neural oscillations in continuous performance tasks. Neuroimage. 62: 1867-76. PMID 22691613 DOI: 10.1016/j.neuroimage.2012.06.009  0.411
2012 Balla A, Schneider S, Sershen H, Javitt DC. Effects of novel, high affinity glycine transport inhibitors on frontostriatal dopamine release in a rodent model of schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 902-10. PMID 22561005 DOI: 10.1016/j.euroneuro.2012.03.006  0.427
2012 Trémeau F, Nolan KA, Malaspina D, Javitt DC. Behavioral validation of avolition in schizophrenia. Schizophrenia Research. 138: 255-61. PMID 22398126 DOI: 10.1016/j.schres.2012.02.018  0.384
2012 Gold R, Butler P, Revheim N, Leitman DI, Hansen JA, Gur RC, Kantrowitz JT, Laukka P, Juslin PN, Silipo GS, Javitt DC. Auditory emotion recognition impairments in schizophrenia: relationship to acoustic features and cognition. The American Journal of Psychiatry. 169: 424-32. PMID 22362394 DOI: 10.1176/Appi.Ajp.2011.11081230  0.791
2012 Kantrowitz J, Javitt DC. Glutamatergic transmission in schizophrenia: from basic research to clinical practice. Current Opinion in Psychiatry. 25: 96-102. PMID 22297716 DOI: 10.1097/YCO.0b013e32835035b2  0.34
2012 Friedman T, Sehatpour P, Dias E, Perrin M, Javitt DC. Differential relationships of mismatch negativity and visual p1 deficits to premorbid characteristics and functional outcome in schizophrenia. Biological Psychiatry. 71: 521-9. PMID 22192361 DOI: 10.1016/J.Biopsych.2011.10.037  0.84
2012 Javitt DC, Buchanan RW, Keefe RS, Kern R, McMahon RP, Green MF, Lieberman J, Goff DC, Csernansky JG, McEvoy JP, Jarskog F, Seidman LJ, Gold JM, Kimhy D, Nolan KS, et al. Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophrenia Research. 136: 25-31. PMID 22169248 DOI: 10.1016/J.Schres.2011.11.001  0.436
2012 Yang L, Chen S, Chen CM, Khan F, Forchelli G, Javitt DC. Schizophrenia, culture and neuropsychology: sensory deficits, language impairments and social functioning in Chinese-speaking schizophrenia patients. Psychological Medicine. 42: 1485-94. PMID 22099474 DOI: 10.1017/S0033291711002224  0.452
2012 Moghaddam B, Javitt D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 4-15. PMID 21956446 DOI: 10.1038/npp.2011.181  0.451
2012 Martínez A, Hillyard SA, Bickel S, Dias EC, Butler PD, Javitt DC. Consequences of magnocellular dysfunction on processing attended information in schizophrenia. Cerebral Cortex (New York, N.Y. : 1991). 22: 1282-93. PMID 21840846 DOI: 10.1093/cercor/bhr195  0.537
2012 Gelfin E, Kaufman Y, Korn-Lubetzki I, Bloch B, Kremer I, Javitt DC, Heresco-Levy U. D-serine adjuvant treatment alleviates behavioural and motor symptoms in Parkinson's disease. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 543-9. PMID 21733283 DOI: 10.1017/S1461145711001015  0.346
2012 Hoptman MJ, Kantrowitz JT, Butler PD, Lehrfeld JM, Calderone D, D'Angelo D, Mauro CJ, Parker EM, Javitt DC. Differential patterns of functional dysconnectivity underlying impairments in mismatch negativity generation and voice emotion recognition in schizophrenia: a resting state fMRI analysis F1000research. 3. DOI: 10.7490/F1000Research.1090835.1  0.772
2012 Spering M, Dias EC, Sanchez JL, Schutz AC, Javitt DC. Smooth pursuit eye movements and motion prediction in patients with schizophrenia and untrained healthy controls F1000research. 3. DOI: 10.7490/F1000Research.1090402.1  0.67
2012 Spering M, Dias EC, Sanchez JL, Schutz AC, Javitt DC.  Pursuit eye movements and motion prediction in patients with schizophrenia Journal of Vision. 12: 999-999. DOI: 10.1167/12.9.999  0.669
2012 Kantrowitz JT, Friedman T, Oakman E, Scaramello N, Gomez D, Silipo G, Javitt DC. Poster #196 HIGH DOSE D-SERINE IN THE TREATMENT OF SCHIZOPHRENIA Schizophrenia Research. 136: S351. DOI: 10.1016/S0920-9964(12)71028-9  0.806
2011 Leitman DI, Sehatpour P, Garidis C, Gomez-Ramirez M, Javitt DC. Preliminary Evidence of Pre-Attentive Distinctions of Frequency-Modulated Tones that Convey Affect. Frontiers in Human Neuroscience. 5: 96. PMID 22053152 DOI: 10.3389/Fnhum.2011.00096  0.796
2011 Javitt DC, Schoepp D, Kalivas PW, Volkow ND, Zarate C, Merchant K, Bear MF, Umbricht D, Hajos M, Potter WZ, Lee CM. Translating glutamate: from pathophysiology to treatment. Science Translational Medicine. 3: 102mr2. PMID 21957170 DOI: 10.1126/Scitranslmed.3002804  0.325
2011 Knebel JF, Javitt DC, Murray MM. Impaired early visual response modulations to spatial information in chronic schizophrenia. Psychiatry Research. 193: 168-76. PMID 21764264 DOI: 10.1016/j.pscychresns.2011.02.006  0.556
2011 Jacobson L, Javitt DC, Lavidor M. Activation of inhibition: diminishing impulsive behavior by direct current stimulation over the inferior frontal gyrus. Journal of Cognitive Neuroscience. 23: 3380-7. PMID 21452949 DOI: 10.1162/jocn_a_00020  0.342
2011 Dias EC, Butler PD, Hoptman MJ, Javitt DC. Early sensory contributions to contextual encoding deficits in schizophrenia. Archives of General Psychiatry. 68: 654-64. PMID 21383251 DOI: 10.1001/archgenpsychiatry.2011.17  0.73
2011 Smiley JF, Rosoklija G, Mancevski B, Pergolizzi D, Figarsky K, Bleiwas C, Duma A, Mann JJ, Javitt DC, Dwork AJ. Hemispheric comparisons of neuron density in the planum temporale of schizophrenia and nonpsychiatric brains. Psychiatry Research. 192: 1-11. PMID 21377842 DOI: 10.1016/J.Pscychresns.2010.11.007  0.399
2011 Buchanan RW, Keefe RS, Lieberman JA, Barch DM, Csernansky JG, Goff DC, Gold JM, Green MF, Jarskog LF, Javitt DC, Kimhy D, Kraus MS, McEvoy JP, Mesholam-Gately RI, Seidman LJ, et al. A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biological Psychiatry. 69: 442-9. PMID 21145041 DOI: 10.1016/J.Biopsych.2010.09.052  0.456
2011 Luck SJ, Mathalon DH, O'Donnell BF, Hämäläinen MS, Spencer KM, Javitt DC, Uhlhaas PJ. A roadmap for the development and validation of event-related potential biomarkers in schizophrenia research. Biological Psychiatry. 70: 28-34. PMID 21111401 DOI: 10.1016/J.Biopsych.2010.09.021  0.42
2011 Nemrodov D, Harpaz Y, Javitt DC, Lavidor M. ERP evidence of hemispheric independence in visual word recognition. Brain and Language. 118: 72-80. PMID 20542549 DOI: 10.1016/J.Bandl.2010.04.004  0.361
2011 Nair-Collins S, Mauro CJ, Javitt DC, Hoptman MJ. Assessing resting state functional connectivity in people with schizophrenia and healthy controls F1000research. 2. DOI: 10.7490/F1000Research.739.1  0.68
2011 Leitman DI, Ziwich R, Pasternak R, Javitt DC. Theory of Mind (ToM) and counterfactuality deficits in schizophrenia: misperception or misinterpretation? – Corrigendum Psychological Medicine. 44. DOI: 10.1017/S003329171100170X  0.767
2011 Kantrowitz JT, Javitt DC. Glutamate: New hope for Schizophrenia treatment Current Psychiatry. 10: 69-74.  0.309
2010 Kantrowitz JT, Javitt DC. Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models. Clinical Schizophrenia & Related Psychoses. 4: 189-200. PMID 20880830 DOI: 10.3371/CSRP.4.3.6  0.47
2010 Javitt DC. Glutamatergic theories of schizophrenia. The Israel Journal of Psychiatry and Related Sciences. 47: 4-16. PMID 20686195  0.305
2010 Sehatpour P, Dias EC, Butler PD, Revheim N, Guilfoyle DN, Foxe JJ, Javitt DC. Impaired visual object processing across an occipital-frontal-hippocampal brain network in schizophrenia: an integrated neuroimaging study. Archives of General Psychiatry. 67: 772-82. PMID 20679585 DOI: 10.1001/archgenpsychiatry.2010.85  0.739
2010 Perrin MA, Butler PD, DiCostanzo J, Forchelli G, Silipo G, Javitt DC. Spatial localization deficits and auditory cortical dysfunction in schizophrenia. Schizophrenia Research. 124: 161-8. PMID 20619608 DOI: 10.1016/J.Schres.2010.06.004  0.736
2010 Kantrowitz JT, Malhotra AK, Cornblatt B, Silipo G, Balla A, Suckow RF, D'Souza C, Saksa J, Woods SW, Javitt DC. High dose D-serine in the treatment of schizophrenia. Schizophrenia Research. 121: 125-30. PMID 20541910 DOI: 10.1016/j.schres.2010.05.012  0.359
2010 Leitman DI, Sehatpour P, Higgins BA, Foxe JJ, Silipo G, Javitt DC. Sensory deficits and distributed hierarchical dysfunction in schizophrenia. The American Journal of Psychiatry. 167: 818-27. PMID 20478875 DOI: 10.1176/Appi.Ajp.2010.09030338  0.848
2010 Kantrowitz JT, Oakman E, Bickel S, Citrome L, Spielman A, Silipo G, Battaglia J, Javitt DC. The importance of a good night's sleep: an open-label trial of the sodium salt of gamma-hydroxybutyric acid in insomnia associated with schizophrenia. Schizophrenia Research. 120: 225-6. PMID 20435443 DOI: 10.1016/j.schres.2010.03.035  0.34
2010 Kantrowitz JT, Javitt DC. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Research Bulletin. 83: 108-21. PMID 20417696 DOI: 10.1016/j.brainresbull.2010.04.006  0.465
2010 Leitman DI, Wolf DH, Ragland JD, Laukka P, Loughead J, Valdez JN, Javitt DC, Turetsky BI, Gur RC. "It's Not What You Say, But How You Say it": A Reciprocal Temporo-frontal Network for Affective Prosody. Frontiers in Human Neuroscience. 4: 19. PMID 20204074 DOI: 10.3389/Fnhum.2010.00019  0.761
2010 Butler PD, Schechter I, Revheim N, Silipo G, Javitt DC. Has an important test been overlooked? Closure flexibility in schizophrenia. Schizophrenia Research. 118: 20-5. PMID 20110157 DOI: 10.1016/j.schres.2010.01.005  0.521
2010 Trémeau F, Antonius D, Cacioppo JT, Ziwich R, Butler P, Malaspina D, Javitt DC. Anticipated, on-line and remembered positive experience in schizophrenia. Schizophrenia Research. 122: 199-205. PMID 19906511 DOI: 10.1016/J.Schres.2009.10.019  0.51
2010 Hoptman MJ, Zuo XN, Butler PD, Javitt DC, D'Angelo D, Mauro CJ, Milham MP. Amplitude of low-frequency oscillations in schizophrenia: a resting state fMRI study. Schizophrenia Research. 117: 13-20. PMID 19854028 DOI: 10.1016/J.Schres.2009.09.030  0.676
2010 Hoptman MJ, D'Angelo D, Catalano D, Mauro CJ, Shehzad ZE, Kelly AM, Castellanos FX, Javitt DC, Milham MP. Amygdalofrontal functional disconnectivity and aggression in schizophrenia. Schizophrenia Bulletin. 36: 1020-8. PMID 19336392 DOI: 10.1093/Schbul/Sbp012  0.704
2010 Wylie GR, Clark EA, Butler PD, Javitt DC. Schizophrenia patients show task switching deficits consistent with N-methyl-d-aspartate system dysfunction but not global executive deficits: implications for pathophysiology of executive dysfunction in schizophrenia. Schizophrenia Bulletin. 36: 585-94. PMID 18835838 DOI: 10.1093/schbul/sbn119  0.709
2010 Leitman DI, Laukka P, Juslin PN, Saccente E, Butler P, Javitt DC. Getting the cue: sensory contributions to auditory emotion recognition impairments in schizophrenia. Schizophrenia Bulletin. 36: 545-56. PMID 18791077 DOI: 10.1093/Schbul/Sbn115  0.778
2010 Buchanan RW, Barch D, Csernansky J, Goff D, Gold J, Jarskog F, Javitt D, Keefe R, Lieberman J, McEvoy J, McMahon R, Marder S. MK-0777 FOR THE TREATMENT OF COGNITIVE IMPAIRMENTS IN PEOPLE WITH SCHIZOPHRENIA Schizophrenia Research. 117: 119. DOI: 10.1016/J.Schres.2010.02.053  0.44
2009 Leitman DI, Sehatpour P, Shpaner M, Foxe JJ, Javitt DC. Mismatch negativity to tonal contours suggests preattentive perception of prosodic content. Brain Imaging and Behavior. 3: 284-91. PMID 22005991 DOI: 10.1007/S11682-009-9070-7  0.803
2009 Lakatos P, O'Connell MN, Barczak A, Mills A, Javitt DC, Schroeder CE. The leading sense: supramodal control of neurophysiological context by attention. Neuron. 64: 419-30. PMID 19914189 DOI: 10.1016/J.Neuron.2009.10.014  0.358
2009 Javitt DC. Sensory processing in schizophrenia: neither simple nor intact. Schizophrenia Bulletin. 35: 1059-64. PMID 19833806 DOI: 10.1093/schbul/sbp110  0.504
2009 Butler PD, Abeles IY, Weiskopf NG, Tambini A, Jalbrzikowski M, Legatt ME, Zemon V, Loughead J, Gur RC, Javitt DC. Sensory contributions to impaired emotion processing in schizophrenia. Schizophrenia Bulletin. 35: 1095-107. PMID 19793797 DOI: 10.1093/Schbul/Sbp109  0.741
2009 Kantrowitz JT, Butler PD, Schecter I, Silipo G, Javitt DC. Seeing the world dimly: the impact of early visual deficits on visual experience in schizophrenia. Schizophrenia Bulletin. 35: 1085-94. PMID 19793795 DOI: 10.1093/schbul/sbp100  0.462
2009 Kantrowitz JT, Citrome L, Javitt DC. A review of tolerability and abuse liability of gamma-hydroxybutyric acid for insomnia in patients with schizophrenia. Clinical Therapeutics. 31: 1360-73. PMID 19698899 DOI: 10.1016/j.clinthera.2009.07.005  0.377
2009 Smiley JF, Rosoklija G, Mancevski B, Mann JJ, Dwork AJ, Javitt DC. Altered volume and hemispheric asymmetry of the superficial cortical layers in the schizophrenia planum temporale. The European Journal of Neuroscience. 30: 449-63. PMID 19656176 DOI: 10.1111/J.1460-9568.2009.06838.X  0.439
2009 Kantrowitz J, Citrome L, Javitt D. GABAB receptors, schizophrenia and sleep dysfunction: A review of the relationship and its potential clinical and therapeutic implications Cns Drugs. 23: 681-691. PMID 19594197 DOI: 10.2165/00023210-200923080-00005  0.365
2009 Kantrowitz JT, Revheim N, Pasternak R, Silipo G, Javitt DC. It's all in the cards: effect of stimulus manipulation on Wisconsin Card Sorting Test performance in schizophrenia. Psychiatry Research. 168: 198-204. PMID 19573928 DOI: 10.1016/j.psychres.2008.05.013  0.5
2009 Javitt DC. Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification. Current Opinion in Drug Discovery & Development. 12: 468-78. PMID 19562643  0.342
2009 Bickel S, Javitt DC. Neurophysiological and neurochemical animal models of schizophrenia: focus on glutamate. Behavioural Brain Research. 204: 352-62. PMID 19433116 DOI: 10.1016/j.bbr.2009.05.005  0.458
2009 Balla A, Nattini ME, Sershen H, Lajtha A, Dunlop DS, Javitt DC. GABAB/NMDA receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum. Neuropharmacology. 56: 915-21. PMID 19371582 DOI: 10.1016/j.neuropharm.2009.01.021  0.317
2009 Javitt DC. When doors of perception close: bottom-up models of disrupted cognition in schizophrenia. Annual Review of Clinical Psychology. 5: 249-75. PMID 19327031 DOI: 10.1146/annurev.clinpsy.032408.153502  0.529
2009 Greenberg WM, Benedict MM, Doerfer J, Perrin M, Panek L, Cleveland WL, Javitt DC. Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults. Journal of Psychiatric Research. 43: 664-70. PMID 19046587 DOI: 10.1016/J.Jpsychires.2008.10.007  0.636
2009 Trémeau F, Antonius D, Cacioppo JT, Ziwich R, Jalbrzikowski M, Saccente E, Silipo G, Butler P, Javitt D. In support of Bleuler: objective evidence for increased affective ambivalence in schizophrenia based upon evocative testing. Schizophrenia Research. 107: 223-31. PMID 18947981 DOI: 10.1016/J.Schres.2008.09.020  0.73
2009 Wylie GR, Murray MM, Javitt DC, Foxe JJ. Distinct neurophysiological mechanisms mediate mixing costs and switch costs. Journal of Cognitive Neuroscience. 21: 105-18. PMID 18476759 DOI: 10.1162/jocn.2009.21009  0.731
2009 Amiaz R, Gershon A, Vainiger D, Weiser M, Lavidor M, Javitt D. P.1.g.006 TMS over the dorsal visual pathway generates schizophrenia-like visual-deficit in healthy controls European Neuropsychopharmacology. 19: S323-S324. DOI: 10.1016/S0924-977X(09)70485-7  0.459
2008 Martínez A, Hillyard SA, Dias EC, Hagler DJ, Butler PD, Guilfoyle DN, Jalbrzikowski M, Silipo G, Javitt DC. Magnocellular pathway impairment in schizophrenia: evidence from functional magnetic resonance imaging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 7492-500. PMID 18650327 DOI: 10.1523/Jneurosci.1852-08.2008  0.744
2008 Trémeau F, Brady M, Saccente E, Moreno A, Epstein H, Citrome L, Malaspina D, Javitt D. Loss aversion in schizophrenia. Schizophrenia Research. 103: 121-8. PMID 18501565 DOI: 10.1016/j.schres.2008.03.027  0.385
2008 Javitt DC. Phenomenology, aetiology and treatment of schizophrenia. Novartis Foundation Symposium. 289: 4-16; discussion 17-. PMID 18497092 DOI: 10.1002/9780470751251.Ch2  0.463
2008 McCourt ME, Shpaner M, Javitt DC, Foxe JJ. Hemispheric asymmetry and callosal integration of visuospatial attention in schizophrenia: a tachistoscopic line bisection study. Schizophrenia Research. 102: 189-96. PMID 18485672 DOI: 10.1016/J.Schres.2008.03.021  0.678
2008 Butler PD, Tambini A, Yovel G, Jalbrzikowski M, Ziwich R, Silipo G, Kanwisher N, Javitt DC. What's in a face? Effects of stimulus duration and inversion on face processing in schizophrenia. Schizophrenia Research. 103: 283-92. PMID 18450426 DOI: 10.1016/J.Schres.2008.03.007  0.711
2008 Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S, Grace AA. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends in Neurosciences. 31: 234-42. PMID 18395805 DOI: 10.1016/J.Tins.2008.02.005  0.456
2008 Sehatpour P, Molholm S, Schwartz TH, Mahoney JR, Mehta AD, Javitt DC, Stanton PK, Foxe JJ. A human intracranial study of long-range oscillatory coherence across a frontal-occipital-hippocampal brain network during visual object processing. Proceedings of the National Academy of Sciences of the United States of America. 105: 4399-404. PMID 18334648 DOI: 10.1073/Pnas.0708418105  0.646
2008 Javitt DC. Glycine transport inhibitors and the treatment of schizophrenia. Biological Psychiatry. 63: 6-8. PMID 18082555 DOI: 10.1016/j.biopsych.2007.09.017  0.402
2008 Javitt DC, Spencer KM, Thaker GK, Winterer G, Hajós M. Neurophysiological biomarkers for drug development in schizophrenia. Nature Reviews. Drug Discovery. 7: 68-83. PMID 18064038 DOI: 10.1038/Nrd2463  0.481
2008 Donohoe G, Morris DW, De Sanctis P, Magno E, Montesi JL, Garavan HP, Robertson IH, Javitt DC, Gill M, Corvin AP, Foxe JJ. Early visual processing deficits in dysbindin-associated schizophrenia. Biological Psychiatry. 63: 484-9. PMID 17945199 DOI: 10.1016/J.Biopsych.2007.07.022  0.734
2008 Sershen H, Balla A, Aspromonte JM, Xie S, Cooper TB, Javitt DC. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function. Neurochemistry International. 52: 119-29. PMID 17716783 DOI: 10.1016/j.neuint.2007.07.011  0.334
2008 Kalkstein S, Wylie GR, Clark E, Butler P, Javitt DC. EXECUTIVE CONTROL IN SCHIZOPHRENIA: SCHIZOPHRENIA PATIENTS SHOW TASK SWITCHING DEFICITS CONSISTENT WITH NMDA DYSFUNCTION, BUT NOT GLOBAL EXECUTIVE DEFICITS: IMPLICATIONS FOR PATHOPATHOLOGY Schizophrenia Research. 102: 140. DOI: 10.1016/S0920-9964(08)70426-2  0.719
2008 Butler P, Pasternak R, Javitt D, Kurylo D. PERCEPTUAL ORGANIZATION OF SIMILARITY AND PROXIMITY IS IMPAIRED IN SCHIZOPHRENIA Schizophrenia Research. 102: 12. DOI: 10.1016/S0920-9964(08)70041-0  0.482
2008 Weiser M, Javitt D, Heresco-Levy U, Abramovitch A, Teitlebaum A, Doron A, Davidson M. D-SERINE VS. PLACEBO IN THE TREATMENT OF NEGATIVE SYMPTOMS AND COGNITIVE IMPAIRMENT OF SCHIZOPHRENIA Schizophrenia Research. 102: 8. DOI: 10.1016/S0920-9964(08)70025-2  0.438
2008 Martínez A, Hillyard SA, Dias EC, Hagler DJ, Butler PD, Guilfoyle DN, Jalbrzikowski M, Silipo G, Javitt DC. Magnocellular pathway impairment in schizophrenia: Evidence from functional magnetic resonance imaging (Journal of Neuroscience (July 23, 2008) (7492-7500)) Journal of Neuroscience. 28: 9319.  0.642
2007 Ross LA, Saint-Amour D, Leavitt VM, Molholm S, Javitt DC, Foxe JJ. Impaired multisensory processing in schizophrenia: deficits in the visual enhancement of speech comprehension under noisy environmental conditions. Schizophrenia Research. 97: 173-83. PMID 17928202 DOI: 10.1016/j.schres.2007.08.008  0.744
2007 Buchanan RW, Javitt DC, Marder SR, Schooler NR, Gold JM, McMahon RP, Heresco-Levy U, Carpenter WT. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. The American Journal of Psychiatry. 164: 1593-602. PMID 17898352 DOI: 10.1176/Appi.Ajp.2007.06081358  0.404
2007 Kimhy D, Corcoran C, Harkavy-Friedman JM, Ritzler B, Javitt DC, Malaspina D. Visual form perception: a comparison of individuals at high risk for psychosis, recent onset schizophrenia and chronic schizophrenia. Schizophrenia Research. 97: 25-34. PMID 17884347 DOI: 10.1016/J.Schres.2007.08.022  0.485
2007 Kurylo DD, Pasternak R, Silipo G, Javitt DC, Butler PD. Perceptual organization by proximity and similarity in schizophrenia. Schizophrenia Research. 95: 205-14. PMID 17681736 DOI: 10.1016/j.schres.2007.07.001  0.529
2007 Martinez A, Ramanathan DS, Foxe JJ, Javitt DC, Hillyard SA. The role of spatial attention in the selection of real and illusory objects. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 7963-73. PMID 17652587 DOI: 10.1523/JNEUROSCI.0031-07.2007  0.682
2007 Buchanan RW, Freedman R, Javitt DC, Abi-Dargham A, Lieberman JA. Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia. Schizophrenia Bulletin. 33: 1120-30. PMID 17641146 DOI: 10.1093/Schbul/Sbm083  0.407
2007 Smiley JF, Hackett TA, Ulbert I, Karmas G, Lakatos P, Javitt DC, Schroeder CE. Multisensory convergence in auditory cortex, I. Cortical connections of the caudal superior temporal plane in macaque monkeys. The Journal of Comparative Neurology. 502: 894-923. PMID 17447261 DOI: 10.1002/Cne.21325  0.324
2007 Linn GS, O'Keeffe RT, Lifshitz K, Schroeder C, Javitt DC. Behavioral effects of orally administered glycine in socially housed monkeys chronically treated with phencyclidine. Psychopharmacology. 192: 27-38. PMID 17393142 DOI: 10.1007/s00213-007-0771-6  0.429
2007 Javitt DC. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. International Review of Neurobiology. 78: 69-108. PMID 17349858 DOI: 10.1016/S0074-7742(06)78003-5  0.477
2007 Leitman DI, Hoptman MJ, Foxe JJ, Saccente E, Wylie GR, Nierenberg J, Jalbrzikowski M, Lim KO, Javitt DC. The neural substrates of impaired prosodic detection in schizophrenia and its sensorial antecedents. The American Journal of Psychiatry. 164: 474-82. PMID 17329473 DOI: 10.1176/Ajp.2007.164.3.474  0.845
2007 Javitt DC, Rabinowicz E, Silipo G, Dias EC. Encoding vs. retention: differential effects of cue manipulation on working memory performance in schizophrenia. Schizophrenia Research. 91: 159-68. PMID 17291722 DOI: 10.1016/j.schres.2006.11.024  0.442
2007 Heresco-Levy U, Bar G, Levin R, Ermilov M, Ebstein RP, Javitt DC. High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients. Schizophrenia Research. 91: 14-21. PMID 17276036 DOI: 10.1016/j.schres.2006.12.003  0.509
2007 Butler PD, Martinez A, Foxe JJ, Kim D, Zemon V, Silipo G, Mahoney J, Shpaner M, Jalbrzikowski M, Javitt DC. Subcortical visual dysfunction in schizophrenia drives secondary cortical impairments. Brain : a Journal of Neurology. 130: 417-30. PMID 16984902 DOI: 10.1093/Brain/Awl233  0.835
2007 Chen CM, Lakatos P, Shah AS, Mehta AD, Givre SJ, Javitt DC, Schroeder CE. Functional anatomy and interaction of fast and slow visual pathways in macaque monkeys. Cerebral Cortex (New York, N.Y. : 1991). 17: 1561-9. PMID 16950866 DOI: 10.1093/Cercor/Bhl067  0.302
2007 Ross LA, Saint-Amour D, Leavitt VM, Javitt DC, Foxe JJ. Do you see what I am saying? Exploring visual enhancement of speech comprehension in noisy environments. Cerebral Cortex (New York, N.Y. : 1991). 17: 1147-53. PMID 16785256 DOI: 10.1093/cercor/bhl024  0.632
2007 Butler PD, Martinez A, Foxe JJ, Kim D, Zemon V, Silipo G, Mahoney J, Shpaner M, Jalbrzikowskil M, Javitt DC. Reply: A few remarks on assessing magnocellular sensitivity in patients with schizophrenia [2] Brain. 130: e84. DOI: 10.1093/Brain/Awm154  0.758
2007 Ermilov M, Elran S, Levin R, Edelman S, Javitt D, Heresco-Levy U. P.1.g.006 Emotion recognition vs. non-affective visual processing deficits in schizophrenia European Neuropsychopharmacology. 17. DOI: 10.1016/S0924-977X(07)70432-7  0.47
2006 Murray MM, Imber ML, Javitt DC, Foxe JJ. Boundary completion is automatic and dissociable from shape discrimination. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 12043-54. PMID 17108178 DOI: 10.1523/JNEUROSCI.3225-06.2006  0.654
2006 Yeap S, Kelly SP, Sehatpour P, Magno E, Javitt DC, Garavan H, Thakore JH, Foxe JJ. Early visual sensory deficits as endophenotypes for schizophrenia: high-density electrical mapping in clinically unaffected first-degree relatives. Archives of General Psychiatry. 63: 1180-8. PMID 17088498 DOI: 10.1001/archpsyc.63.11.1180  0.751
2006 Butler PD, Hoptman MJ, Nierenberg J, Foxe JJ, Javitt DC, Lim KO. Visual white matter integrity in schizophrenia. The American Journal of Psychiatry. 163: 2011-3. PMID 17074957 DOI: 10.1176/appi.ajp.163.11.2011  0.797
2006 Lim KO, Ardekani BA, Nierenberg J, Butler PD, Javitt DC, Hoptman MJ. Voxelwise correlational analyses of white matter integrity in multiple cognitive domains in schizophrenia. The American Journal of Psychiatry. 163: 2008-10. PMID 17074956 DOI: 10.1176/appi.ajp.163.11.2008  0.687
2006 Ritter W, De Sanctis P, Molholm S, Javitt DC, Foxe JJ. Preattentively grouped tones do not elicit MMN with respect to each other. Psychophysiology. 43: 423-30. PMID 16965603 DOI: 10.1111/j.1469-8986.2006.00423.x  0.601
2006 Schechter I, Butler PD, Jalbrzikowski M, Pasternak R, Saperstein AM, Javitt DC. A new dimension of sensory dysfunction: stereopsis deficits in schizophrenia. Biological Psychiatry. 60: 1282-4. PMID 16945346 DOI: 10.1016/J.Biopsych.2006.03.064  0.748
2006 Revheim N, Butler PD, Schechter I, Jalbrzikowski M, Silipo G, Javitt DC. Reading impairment and visual processing deficits in schizophrenia. Schizophrenia Research. 87: 238-45. PMID 16890409 DOI: 10.1016/J.Schres.2006.06.022  0.734
2006 Leitman DI, Ziwich R, Pasternak R, Javitt DC. Theory of Mind (ToM) and counterfactuality deficits in schizophrenia: misperception or misinterpretation? Psychological Medicine. 36: 1075-83. PMID 16700967 DOI: 10.1017/S0033291706007653  0.796
2006 Heresco-Levy U, Javitt DC, Gelfin Y, Gorelik E, Bar M, Blanaru M, Kremer I. Controlled trial of D-cycloserine adjuvant therapy for treatment-resistant major depressive disorder. Journal of Affective Disorders. 93: 239-43. PMID 16677714 DOI: 10.1016/j.jad.2006.03.004  0.465
2006 Dias EC, McGinnis T, Smiley JF, Foxe JJ, Schroeder CE, Javitt DC. Changing plans: neural correlates of executive control in monkey and human frontal cortex. Experimental Brain Research. 174: 279-91. PMID 16636795 DOI: 10.1007/s00221-006-0444-4  0.653
2006 Javitt DC. Is the glycine site half saturated or half unsaturated? Effects of glutamatergic drugs in schizophrenia patients. Current Opinion in Psychiatry. 19: 151-7. PMID 16612195 DOI: 10.1097/01.yco.0000214340.14131.bd  0.375
2006 Umbricht DS, Bates JA, Lieberman JA, Kane JM, Javitt DC. Electrophysiological indices of automatic and controlled auditory information processing in first-episode, recent-onset and chronic schizophrenia. Biological Psychiatry. 59: 762-72. PMID 16497277 DOI: 10.1016/J.Biopsych.2005.08.030  0.469
2006 Martínez A, Teder-Sälejärvi W, Vazquez M, Molholm S, Foxe JJ, Javitt DC, Di Russo F, Worden MS, Hillyard SA. Objects are highlighted by spatial attention. Journal of Cognitive Neuroscience. 18: 298-310. PMID 16494688 DOI: 10.1162/089892906775783642  0.65
2006 Revheim N, Schechter I, Kim D, Silipo G, Allingham B, Butler P, Javitt DC. Neurocognitive and symptom correlates of daily problem-solving skills in schizophrenia. Schizophrenia Research. 83: 237-45. PMID 16443347 DOI: 10.1016/J.Schres.2005.12.849  0.377
2006 Kim D, Wylie G, Pasternak R, Butler PD, Javitt DC. Magnocellular contributions to impaired motion processing in schizophrenia. Schizophrenia Research. 82: 1-8. PMID 16325377 DOI: 10.1016/J.Schres.2005.10.008  0.711
2006 Sehatpour P, Molholm S, Javitt DC, Foxe JJ. Spatiotemporal dynamics of human object recognition processing: an integrated high-density electrical mapping and functional imaging study of "closure" processes. Neuroimage. 29: 605-18. PMID 16168676 DOI: 10.1016/j.neuroimage.2005.07.049  0.655
2006 Wylie GR, Javitt DC, Foxe JJ. Jumping the gun: is effective preparation contingent upon anticipatory activation in task-relevant neural circuitry? Cerebral Cortex (New York, N.Y. : 1991). 16: 394-404. PMID 15917482 DOI: 10.1093/cercor/bhi118  0.737
2005 Butler PD, Javitt DC. Early-stage visual processing deficits in schizophrenia. Current Opinion in Psychiatry. 18: 151-7. PMID 16639168 DOI: 10.1097/00001504-200503000-00008  0.528
2005 Neeman G, Blanaru M, Bloch B, Kremer I, Ermilov M, Javitt DC, Heresco-Levy U. Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type. The American Journal of Psychiatry. 162: 1738-40. PMID 16135636 DOI: 10.1176/appi.ajp.162.9.1738  0.438
2005 Ardekani BA, Bappal A, D'Angelo D, Ashtari M, Lencz T, Szeszko PR, Butler PD, Javitt DC, Lim KO, Hrabe J, Nierenberg J, Branch CA, Hoptman MJ. Brain morphometry using diffusion-weighted magnetic resonance imaging: application to schizophrenia. Neuroreport. 16: 1455-9. PMID 16110271 DOI: 10.1097/01.Wnr.0000177001.27569.06  0.644
2005 Schechter I, Butler PD, Zemon VM, Revheim N, Saperstein AM, Jalbrzikowski M, Pasternak R, Silipo G, Javitt DC. Impairments in generation of early-stage transient visual evoked potentials to magno- and parvocellular-selective stimuli in schizophrenia. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 116: 2204-15. PMID 16055375 DOI: 10.1016/J.Clinph.2005.06.013  0.702
2005 Leitman DI, Foxe JJ, Butler PD, Saperstein A, Revheim N, Javitt DC. Sensory contributions to impaired prosodic processing in schizophrenia. Biological Psychiatry. 58: 56-61. PMID 15992523 DOI: 10.1016/J.Biopsych.2005.02.034  0.847
2005 Kim D, Zemon V, Saperstein A, Butler PD, Javitt DC. Dysfunction of early-stage visual processing in schizophrenia: harmonic analysis. Schizophrenia Research. 76: 55-65. PMID 15927798 DOI: 10.1016/J.Schres.2004.10.011  0.522
2005 Butler PD, Zemon V, Schechter I, Saperstein AM, Hoptman MJ, Lim KO, Revheim N, Silipo G, Javitt DC. Early-stage visual processing and cortical amplification deficits in schizophrenia. Archives of General Psychiatry. 62: 495-504. PMID 15867102 DOI: 10.1001/archpsyc.62.5.495  0.722
2005 Heresco-Levy U, Javitt DC, Ebstein R, Vass A, Lichtenberg P, Bar G, Catinari S, Ermilov M. D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. Biological Psychiatry. 57: 577-85. PMID 15780844 DOI: 10.1016/j.biopsych.2004.12.037  0.423
2005 Foxe JJ, Murray MM, Javitt DC. Filling-in in schizophrenia: a high-density electrical mapping and source-analysis investigation of illusory contour processing. Cerebral Cortex (New York, N.Y. : 1991). 15: 1914-27. PMID 15772373 DOI: 10.1093/cercor/bhi069  0.713
2005 Javitt DC, Hashim A, Sershen H. Modulation of striatal dopamine release by glycine transport inhibitors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 649-56. PMID 15688094 DOI: 10.1038/sj.npp.1300589  0.341
2005 Murray MM, Molholm S, Michel CM, Heslenfeld DJ, Ritter W, Javitt DC, Schroeder CE, Foxe JJ. Grabbing your ear: rapid auditory-somatosensory multisensory interactions in low-level sensory cortices are not constrained by stimulus alignment. Cerebral Cortex (New York, N.Y. : 1991). 15: 963-74. PMID 15537674 DOI: 10.1093/Cercor/Bhh197  0.652
2005 Molholm S, Martinez A, Ritter W, Javitt DC, Foxe JJ. The neural circuitry of pre-attentive auditory change-detection: an fMRI study of pitch and duration mismatch negativity generators. Cerebral Cortex (New York, N.Y. : 1991). 15: 545-51. PMID 15342438 DOI: 10.1093/cercor/bhh155  0.716
2005 Choi I, Lee S, Shen J, Javitt DC. Cerebral GABA decrease in patients with schizophrenia measured by 1|[thinsp]|H MR chemical shift imaging of GABA Journal of Cerebral Blood Flow and Metabolism. 25. DOI: 10.1038/Sj.Jcbfm.9591524.0325  0.312
2004 Hoptman MJ, Ardekani BA, Butler PD, Nierenberg J, Javitt DC, Lim KO. DTI and impulsivity in schizophrenia: a first voxelwise correlational analysis. Neuroreport. 15: 2467-70. PMID 15538176 DOI: 10.1097/00001756-200411150-00007  0.681
2004 Kremer I, Vass A, Gorelik I, Bar G, Blanaru M, Javitt DC, Heresco-Levy U. Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia. Biological Psychiatry. 56: 441-6. PMID 15364042 DOI: 10.1016/j.biopsych.2004.06.029  0.429
2004 Murray MM, Foxe DM, Javitt DC, Foxe JJ. Setting boundaries: brain dynamics of modal and amodal illusory shape completion in humans. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 6898-903. PMID 15295024 DOI: 10.1523/JNEUROSCI.1996-04.2004  0.654
2004 Javitt DC. Glutamate as a therapeutic target in psychiatric disorders. Molecular Psychiatry. 9: 984-97, 979. PMID 15278097 DOI: 10.1038/sj.mp.4001551  0.349
2004 Hester RL, Murphy K, Foxe JJ, Foxe DM, Javitt DC, Garavan H. Predicting success: patterns of cortical activation and deactivation prior to response inhibition. Journal of Cognitive Neuroscience. 16: 776-85. PMID 15200705 DOI: 10.1162/089892904970726  0.66
2004 Fassbender C, Murphy K, Foxe JJ, Wylie GR, Javitt DC, Robertson IH, Garavan H. A topography of executive functions and their interactions revealed by functional magnetic resonance imaging. Brain Research. Cognitive Brain Research. 20: 132-43. PMID 15183386 DOI: 10.1016/j.cogbrainres.2004.02.007  0.75
2004 Kelly AM, Hester R, Murphy K, Javitt DC, Foxe JJ, Garavan H. Prefrontal-subcortical dissociations underlying inhibitory control revealed by event-related fMRI. The European Journal of Neuroscience. 19: 3105-12. PMID 15182319 DOI: 10.1111/j.0953-816X.2004.03429.x  0.65
2004 Wylie GR, Javitt DC, Foxe JJ. The role of response requirements in task switching: dissolving the residue. Neuroreport. 15: 1079-87. PMID 15076739 DOI: 10.1097/00001756-200404290-00030  0.731
2004 Heresco-Levy U, Javitt DC. Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis. Schizophrenia Research. 66: 89-96. PMID 15061240 DOI: 10.1016/S0920-9964(03)00129-4  0.439
2004 Wylie GR, Javitt DC, Foxe JJ. Don't think of a white bear: an fMRI investigation of the effects of sequential instructional sets on cortical activity in a task-switching paradigm. Human Brain Mapping. 21: 279-97. PMID 15038009 DOI: 10.1002/hbm.20003  0.734
2004 Shoham S, Mazeh H, Javitt DC, Heresco-Levy U. Glycine and D-cycloserine attenuate vacuous chewing movements in a rat model of tardive dyskinesia. Brain Research. 1004: 142-7. PMID 15033429 DOI: 10.1016/j.brainres.2004.01.022  0.328
2004 Molholm S, Ritter W, Javitt DC, Foxe JJ. Multisensory visual-auditory object recognition in humans: a high-density electrical mapping study. Cerebral Cortex (New York, N.Y. : 1991). 14: 452-65. PMID 15028649 DOI: 10.1093/cercor/bhh007  0.671
2004 Heresco-Levy U, Ermilov M, Lichtenberg P, Bar G, Javitt DC. High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia. Biological Psychiatry. 55: 165-71. PMID 14732596 DOI: 10.1016/S0006-3223(03)00707-8  0.412
2004 Javitt DC, Coyle JT. Decoding schizophrenia. Scientific American. 290: 48-55. PMID 14682038  0.365
2004 Javitt DC, Balla A, Burch S, Suckow R, Xie S, Sershen H. Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 300-7. PMID 14560321 DOI: 10.1038/sj.npp.1300313  0.429
2003 Wylie GR, Javitt DC, Foxe JJ. Task switching: a high-density electrical mapping study. Neuroimage. 20: 2322-42. PMID 14683733 DOI: 10.1016/j.neuroimage.2003.08.010  0.747
2003 Schechter I, Butler PD, Silipo G, Zemon V, Javitt DC. Magnocellular and parvocellular contributions to backward masking dysfunction in schizophrenia. Schizophrenia Research. 64: 91-101. PMID 14613674 DOI: 10.1016/S0920-9964(03)00008-2  0.389
2003 Ardekani BA, Nierenberg J, Hoptman MJ, Javitt DC, Lim KO. MRI study of white matter diffusion anisotropy in schizophrenia. Neuroreport. 14: 2025-9. PMID 14600491 DOI: 10.1097/01.wnr.0000093290.85057.0d  0.685
2003 Foxe JJ, McCourt ME, Javitt DC. Right hemisphere control of visuospatial attention: line-bisection judgments evaluated with high-density electrical mapping and source analysis. Neuroimage. 19: 710-26. PMID 12880801 DOI: 10.1016/S1053-8119(03)00057-0  0.656
2003 Linn GS, Negi SS, Gerum SV, Javitt DC. Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys. Psychopharmacology. 169: 234-9. PMID 12845408 DOI: 10.1007/s00213-003-1533-8  0.423
2003 Dias EC, Foxe JJ, Javitt DC. Changing plans: a high density electrical mapping study of cortical control. Cerebral Cortex (New York, N.Y. : 1991). 13: 701-15. PMID 12816885 DOI: 10.1093/cercor/13.7.701  0.691
2003 Wylie GR, Javitt DC, Foxe JJ. Cognitive control processes during an anticipated switch of task. The European Journal of Neuroscience. 17: 667-72. PMID 12581185 DOI: 10.1046/j.1460-9568.2003.02474.x  0.744
2003 Balla A, Sershen H, Serra M, Koneru R, Javitt DC. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 34-44. PMID 12496938 DOI: 10.1038/sj.npp.1300019  0.386
2003 Butler PD, DeSanti LA, Maddox J, Harkavy-Friedman JM, Amador XF, Goetz RR, Javitt DC, Gorman JM. Visual backward-masking deficits in schizophrenia: relationship to visual pathway function and symptomatology. Schizophrenia Research. 59: 199-209. PMID 12414076 DOI: 10.1016/S0920-9964(01)00341-3  0.52
2003 Javitt DC. Peeling the onion: NMDA dysfunction as a unifying model in schizophrenia Behavioral and Brain Sciences. 26: 93-94. DOI: 10.1017/S0140525X0333002X  0.439
2003 Ermilov M, Javitt D, Lichtenberg P, Bar G, Heresco-Levy U. P.2.041 High dose glycine added to olanzapine and risperidone for the treatment of schizophrenia European Neuropsychopharmacology. 13: S296-S297. DOI: 10.1016/S0924-977X(03)91994-8  0.397
2003 Nierenberg J, Hoptman M, Choi S, Butler P, Ardekani B, Revheim N, Javitt D, Lim K. Abnormal white matter integrity in schizophrenia and schizoaffective disorder revealed by diffusion tensor imaging Schizophrenia Research. 60: 203. DOI: 10.1016/S0920-9964(03)81137-4  0.647
2003 Butler P, Lim K, Nierenberg J, Hoptman M, Choi S, Schechter I, Zemon V, Saperstein A, Javitt D. Primary visual dysfunction in schizophrenia: Relationship to white matter integrity inferred from diffusion tensor imaging Schizophrenia Research. 60: 190-191. DOI: 10.1016/S0920-9964(03)81100-3  0.664
2003 Schechter I, Saperstein A, Revheim N, Butler P, Javitt D. Deficits of visual organization in patients with schizophrenia Schizophrenia Research. 60: 182. DOI: 10.1016/S0920-9964(03)81077-0  0.486
2003 Saperstein A, Schechter I, Butler P, Javitt D. Visual pathway deficits in schizophrenia: Varying luminance and spatial frequency in a contrast sensitivity task Schizophrenia Research. 60: 182. DOI: 10.1016/S0920-9964(03)81076-9  0.468
2003 Revheim N, Medalia A, Moscou P, Javitt D. Cognitive remediation and sensory processing deficits in schizophrenia Schizophrenia Research. 60: 180. DOI: 10.1016/S0920-9964(03)81070-8  0.485
2003 Bilder R, Bates J, Turkel E, Lencz T, Gold J, Javitt D, Green M, Park S, Goldman R, Sharma T, Spicer J, Hoptman M, Ashtari M, Marder S, Lieberman J, et al. Computerized neurocognitive assessment: Clinical trials and FMRI applications Schizophrenia Research. 60: 124. DOI: 10.1016/S0920-9964(03)80895-2  0.552
2003 Smiley J, Dwork A, Davceva N, Mancevski B, Duma A, Rosoklija G, Javitt D. Hemispheric asymmetry of the superior temporal cortex in postmortem schizophrenic and control brains Schizophrenia Research. 60: 75. DOI: 10.1016/S0920-9964(03)80608-4  0.329
2003 Umbricht D, Javitt D, Bates J, Kane J, Lieberman J. Deficits in mismatch negativity in schizophrenia: Predictor of outcome or result of illness progression? Schizophrenia Research. 60: 262. DOI: 10.1016/S0920-9964(03)80401-2  0.458
2003 Kim D, Zemon V, Saperstein A, Butler P, Javitt D. Lateral cortical interactions in schizophrenia: A visual evoked potential study Schizophrenia Research. 60: 252. DOI: 10.1016/S0920-9964(03)80372-9  0.49
2002 Doniger GM, Foxe JJ, Murray MM, Higgins BA, Javitt DC. Impaired visual object recognition and dorsal/ventral stream interaction in schizophrenia. Archives of General Psychiatry. 59: 1011-20. PMID 12418934 DOI: 10.1001/Archpsyc.59.11.1011  0.75
2002 Javitt DC. Glycine modulators in schizophrenia. Current Opinion in Investigational Drugs (London, England : 2000). 3: 1067-72. PMID 12186269  0.366
2002 Javitt DC, Cienfuegos A, Miniati M, Silipo G, Levine J, Allingham BH, Robinson J. A naturalistic study of risperidone treatment outcome using prognosis-adjusted discharge rates in New York State inpatients. The Journal of Clinical Psychiatry. 63: 585-90. PMID 12143914 DOI: 10.4088/Jcp.V63N0708  0.303
2002 Foxe JJ, Wylie GR, Martinez A, Schroeder CE, Javitt DC, Guilfoyle D, Ritter W, Murray MM. Auditory-somatosensory multisensory processing in auditory association cortex: an fMRI study. Journal of Neurophysiology. 88: 540-3. PMID 12091578 DOI: 10.1152/Jn.2002.88.1.540  0.778
2002 Murray MM, Wylie GR, Higgins BA, Javitt DC, Schroeder CE, Foxe JJ. The spatiotemporal dynamics of illusory contour processing: combined high-density electrical mapping, source analysis, and functional magnetic resonance imaging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 5055-73. PMID 12077201 DOI: 10.1523/Jneurosci.22-12-05055.2002  0.726
2002 Molholm S, Ritter W, Murray MM, Javitt DC, Schroeder CE, Foxe JJ. Multisensory auditory-visual interactions during early sensory processing in humans: a high-density electrical mapping study. Brain Research. Cognitive Brain Research. 14: 115-28. PMID 12063135 DOI: 10.1016/S0926-6410(02)00066-6  0.674
2002 Javitt DC. Madness in the garden or worm in the apple? Trends in Cognitive Sciences. 6: 187. PMID 11912044 DOI: 10.1016/S0166-2236(00)02124-X  0.469
2002 Heresco-Levy U, Ermilov M, Shimoni J, Shapira B, Silipo G, Javitt DC. Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia. The American Journal of Psychiatry. 159: 480-2. PMID 11870017 DOI: 10.1176/Appi.Ajp.159.3.480  0.349
2002 Javitt DC. Advantages to schizophrenia Trends in Neurosciences. 25: 222. DOI: 10.1016/S0166-2236(00)92124-6  0.473
2001 Javitt DC, Silipo G, Cienfuegos A, Shelley AM, Bark N, Park M, Lindenmayer JP, Suckow R, Zukin SR. Adjunctive high-dose glycine in the treatment of schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 4: 385-91. PMID 11806864 DOI: doi:10.1017/S1461145701002590  0.388
2001 Foxe JJ, Doniger GM, Javitt DC. Early visual processing deficits in schizophrenia: impaired P1 generation revealed by high-density electrical mapping. Neuroreport. 12: 3815-20. PMID 11726801 DOI: 10.1097/00001756-200112040-00043  0.748
2001 Doniger GM, Silipo G, Rabinowicz EF, Snodgrass JG, Javitt DC. Impaired sensory processing as a basis for object-recognition deficits in schizophrenia. The American Journal of Psychiatry. 158: 1818-26. PMID 11691687 DOI: 10.1176/Appi.Ajp.158.11.1818  0.524
2001 Javitt DC. Management of negative symptoms of schizophrenia. Current Psychiatry Reports. 3: 413-7. PMID 11559479 DOI: 10.1007/S11920-996-0036-9  0.414
2001 Javitt DC, Lindsley RW. Effects of phencyclidine on prepulse inhibition of acoustic startle response in the macaque. Psychopharmacology. 156: 165-8. PMID 11549218 DOI: 10.1007/S002130100758  0.447
2001 Moser RK, Cienfuegos A, Barros J, Javitt D. Auditory distraction and thought disorder in chronic schizophrenic inpatients. Evidence for separate contributions by incapacity and poor allocation and a subsyndrome related to the allocation deficit. Schizophrenia Research. 51: 163-70. PMID 11518636 DOI: 10.1016/S0920-9964(00)00122-5  0.375
2001 Fu KM, Foxe JJ, Murray MM, Higgins BA, Javitt DC, Schroeder CE. Attention-dependent suppression of distracter visual input can be cross-modally cued as indexed by anticipatory parieto-occipital alpha-band oscillations. Brain Research. Cognitive Brain Research. 12: 145-52. PMID 11489617 DOI: 10.1016/S0926-6410(01)00034-9  0.67
2001 Butler PD, Schechter I, Zemon V, Schwartz SG, Greenstein VC, Gordon J, Schroeder CE, Javitt DC. Dysfunction of early-stage visual processing in schizophrenia. The American Journal of Psychiatry. 158: 1126-33. PMID 11431235 DOI: 10.1176/Appi.Ajp.158.7.1126  0.488
2001 Balla A, Koneru R, Smiley J, Sershen H, Javitt DC. Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 157-64. PMID 11425499 DOI: 10.1016/S0893-133X(01)00230-5  0.398
2001 Murray MM, Foxe JJ, Higgins BA, Javitt DC, Schroeder CE. Visuo-spatial neural response interactions in early cortical processing during a simple reaction time task: a high-density electrical mapping study. Neuropsychologia. 39: 828-44. PMID 11369406 DOI: 10.1016/S0028-3932(01)00004-5  0.652
2001 Schroeder CE, Lindsley RW, Specht C, Marcovici A, Smiley JF, Javitt DC. Somatosensory input to auditory association cortex in the macaque monkey. Journal of Neurophysiology. 85: 1322-7. PMID 11248001 DOI: 10.1152/Jn.2001.85.3.1322  0.344
2001 Linn GS, Javitt DC. Phencyclidine (PCP)-induced deficits of prepulse inhibition in monkeys. Neuroreport. 12: 117-20. PMID 11201070 DOI: 10.1097/00001756-200101220-00031  0.458
2001 Doniger GM, Foxe JJ, Schroeder CE, Murray MM, Higgins BA, Javitt DC. Visual perceptual learning in human object recognition areas: a repetition priming study using high-density electrical mapping. Neuroimage. 13: 305-13. PMID 11162271 DOI: 10.1006/Nimg.2000.0684  0.63
2000 Rabinowicz EF, Silipo G, Goldman R, Javitt DC. Auditory sensory dysfunction in schizophrenia: imprecision or distractibility? Archives of General Psychiatry. 57: 1149-55. PMID 11115328 DOI: 10.1001/Archpsyc.57.12.1149  0.521
2000 Umbricht D, Schmid L, Koller R, Vollenweider FX, Hell D, Javitt DC. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Archives of General Psychiatry. 57: 1139-47. PMID 11115327 DOI: 10.1001/Archpsyc.57.12.1139  0.509
2000 Javitt DC, Shelley AM, Silipo G, Lieberman JA. Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern. Archives of General Psychiatry. 57: 1131-7. PMID 11115326 DOI: 10.1001/Archpsyc.57.12.1131  0.533
2000 Javitt DC, Shelley A, Ritter W. Associated deficits in mismatch negativity generation and tone matching in schizophrenia. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 111: 1733-7. PMID 11018486 DOI: 10.1016/S1388-2457(00)00377-1  0.537
2000 Foxe JJ, Morocz IA, Murray MM, Higgins BA, Javitt DC, Schroeder CE. Multisensory auditory-somatosensory interactions in early cortical processing revealed by high-density electrical mapping. Brain Research. Cognitive Brain Research. 10: 77-83. PMID 10978694 DOI: 10.1016/S0926-6410(00)00024-0  0.641
2000 Doniger GM, Foxe JJ, Murray MM, Higgins BA, Snodgrass JG, Schroeder CE, Javitt DC. Activation timecourse of ventral visual stream object-recognition areas: high density electrical mapping of perceptual closure processes. Journal of Cognitive Neuroscience. 12: 615-21. PMID 10936914 DOI: 10.1162/089892900562372  0.646
2000 Javitt DC. Intracortical mechanisms of mismatch negativity dysfunction in schizophrenia. Audiology & Neuro-Otology. 5: 207-15. PMID 10859415 DOI: 10.1159/000013882  0.537
2000 Javitt DC, Sershen H, Hashim A, Lajtha A. Inhibition of striatal dopamine release by glycine and glycyldodecylamide. Brain Research Bulletin. 52: 213-6. PMID 10822163 DOI: 10.1016/S0361-9230(00)00258-6  0.333
2000 Javitt DC, Jayachandra M, Lindsley RW, Specht CM, Schroeder CE. Schizophrenia-like deficits in auditory P1 and N1 refractoriness induced by the psychomimetic agent phencyclidine (PCP). Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 111: 833-6. PMID 10802454 DOI: 10.1016/S1388-2457(99)00313-2  0.394
2000 Javitt D, Lindsley R, Schroeder C. 567. NMDA-mediated neurophysiologic deficits in schizophrenia Biological Psychiatry. 47: S173. DOI: 10.1016/S0006-3223(00)00869-6  0.469
1999 Umbricht D, Javitt D, Novak G, Bates J, Pollack S, Lieberman J, Kane J. Effects of risperidone on auditory event-related potentials in schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 2: 299-304. PMID 11285146 DOI: 10.1017/S1461145799001595  0.481
1999 Javitt DC. Treatment of negative and cognitive symptoms. Current Psychiatry Reports. 1: 25-30. PMID 11122902 DOI: 10.1007/S11920-999-0007-Z  0.398
1999 Javitt DC, Liederman E, Cienfuegos A, Shelley AM. Panmodal processing imprecision as a basis for dysfunction of transient memory storage systems in schizophrenia. Schizophrenia Bulletin. 25: 763-75. PMID 10667746 DOI: 10.1093/Oxfordjournals.Schbul.A033417  0.499
1999 Linn GS, O'Keeffe RT, Schroeder CE, Lifshitz K, Javitt DC. Behavioral effects of chronic phencyclidine in monkeys. Neuroreport. 10: 2789-93. PMID 10511441 DOI: 10.1097/00001756-199909090-00017  0.319
1999 Shelley AM, Silipo G, Javitt DC. Diminished responsiveness of ERPs in schizophrenic subjects to changes in auditory stimulation parameters: implications for theories of cortical dysfunction. Schizophrenia Research. 37: 65-79. PMID 10227109 DOI: 10.1016/S0920-9964(98)00138-8  0.535
1999 Javitt DC, Balla A, Sershen H, Lajtha A. A.E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors. Biological Psychiatry. 45: 668-79. PMID 10187996 DOI: 10.1016/S0006-3223(98)00237-6  0.311
1999 March L, Cienfuegos A, Goldbloom L, Ritter W, Cowan N, Javitt DC. Normal time course of auditory recognition in schizophrenia, despite impaired precision of the auditory sensory ("echoic") memory code. Journal of Abnormal Psychology. 108: 69-75. PMID 10066994 DOI: 10.1037//0021-843X.108.1.69  0.472
1999 Cienfuegos A, March L, Shelley AM, Javitt DC. Impaired categorical perception of synthetic speech sounds in schizophrenia. Biological Psychiatry. 45: 82-8. PMID 9894579 DOI: 10.1016/S0006-3223(98)00064-X  0.527
1999 Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Silipo G, Lichtenstein M. Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Archives of General Psychiatry. 56: 29-36. PMID 9892253 DOI: 10.1001/Archpsyc.56.1.29  0.405
1999 March L, Cienfuegos A, Goldbloom L, Ritter W, Cowan N, Javitt DC. Normal time course of auditory recognition in schizophrenia, despite impaired precision of the auditory sensory ("echoic") memory code. Journal of Abnormal Psychology. 108: 69-75. DOI: 10.1037/0021-843X.108.1.69  0.332
1998 Heresco-Levy U, Javitt DC, Ermilov M, Silipo G, Shimoni J. Double-blind, placebo-controlled, crossover trial of D-cycloserine adjuvant therapy for treatment-resistant schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 1: 131-135. PMID 11281957 DOI: 10.1017/S1461145798001242  0.397
1998 Umbricht D, Javitt D, Novak G, Bates J, Pollack S, Lieberman J, Kane J. Effects of clozapine on auditory event-related potentials in schizophrenia. Biological Psychiatry. 44: 716-25. PMID 9798075 DOI: 10.1016/S0006-3223(97)00524-6  0.49
1998 Javitt DC, Grochowski S, Shelley AM, Ritter W. Impaired mismatch negativity (MMN) generation in schizophrenia as a function of stimulus deviance, probability, and interstimulus/interdeviant interval. Electroencephalography and Clinical Neurophysiology. 108: 143-53. PMID 9566627 DOI: 10.1016/S0168-5597(97)00073-7  0.532
1998 Heresco-Levy U, Javitt D, Ermilov M, Mordel C. Glycine and D-Cycloserine adjuvant pharmacotherapy for treatment-resistant schizophrenia Schizophrenia Research. 29: 158. DOI: 10.1016/S0920-9964(97)88705-1  0.403
1998 Umbricht D, Bilder R, Wu H, Javitt D, Kane J. Neuropathological correlates of auditory event-related potentials in recent-onset schizophrenia Schizophrenia Research. 29: 124. DOI: 10.1016/S0920-9964(97)88614-8  0.352
1998 Umbricht D, Javitt D, Bates J, Pollak S, Lieberman J, Kane J. 417. Auditory event-related potentials (ERP) in first episode and chronic schizophrenia Biological Psychiatry. 43. DOI: 10.1016/S0006-3223(98)90865-4  0.469
1998 Umbricht D, Bilder R, Wu H, Javitt D, Kane J. 416. Neuropathological correlates of auditory event-related potentials in recent-onset schizophrenia Biological Psychiatry. 43. DOI: 10.1016/S0006-3223(98)90864-2  0.484
1998 Rabinowicz E, Silipo G, Goldman R, Javitt D. 393. The effects of distractors on auditory sensory memory deficits in schizophrenia Biological Psychiatry. 43: S118. DOI: 10.1016/S0006-3223(98)90841-1  0.415
1997 Winsberg BG, Javitt DC, Silipo GS. Electrophysiological indices of information processing in methylphenidate responders. Biological Psychiatry. 42: 434-45. PMID 9285079 DOI: 10.1016/S0006-3223(96)00429-5  0.326
1997 Javitt DC, Sershen H, Hashim A, Lajtha A. Reversal of phencyclidine-induced hyperactivity by glycine and the glycine uptake inhibitor glycyldodecylamide. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 17: 202-4. PMID 9272487 DOI: 10.1016/S0893-133X(97)00047-X  0.361
1997 Javitt DC, Strous RD, Grochowski S, Ritter W, Cowan N. Impaired precision, but normal retention, of auditory sensory ("echoic") memory information in schizophrenia. Journal of Abnormal Psychology. 106: 315-24. PMID 9131851 DOI: 10.1037//0021-843X.106.2.315  0.371
1997 Javitt DC, Frusciante M. Glycyldodecylamide, a phencyclidine behavioral antagonist, blocks cortical glycine uptake: implications for schizophrenia and substance abuse. Psychopharmacology. 129: 96-8. PMID 9122370 DOI: 10.1007/S002130050168  0.418
1997 Javitt DC. Psychophysiology of schizophrenia Current Opinion in Psychiatry. 10: 11-15. DOI: 10.1097/00001504-199701000-00004  0.485
1997 Umbricht D, Javitt D, Bates J, Pollak S, Lieberman J, Kane J. Event-related potentials (ERP) during a visual working memory task in first episode and chronic schizophrenia Schizophrenia Research. 24: 239. DOI: 10.1016/S0920-9964(97)82689-8  0.433
1997 Umbricht D, Javitt D, Bates J, Pollak S, Lieberman J, Kane J. Auditory event-related potentials (ERP) in first episode and chronic schizophrenia Schizophrenia Research. 24: 238-239. DOI: 10.1016/S0920-9964(97)82688-6  0.469
1997 Shelley A, Javitt DC, Vaughan HG, Silipo G. Encoding vs trace decay: Specifying the mechanism underlying auditory working memory dysfunction in schizophrenia Schizophrenia Research. 24: 238. DOI: 10.1016/S0920-9964(97)82685-0  0.433
1997 Karroos G, Javitt D, Ulbert I, Pincze Z, Molnar M, Csepe V, Schroeder C. Auditory cortical generators of the mismatch-negativity in the cat and monkey — a comparative study International Journal of Psychophysiology. 25: 83. DOI: 10.1016/S0167-8760(97)85580-8  0.333
1996 Javitt DC. Glutamate receptors and schizophrenia: opportunities and caveats. Molecular Psychiatry. 1: 16-7. PMID 9118309  0.303
1996 Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Horowitz A, Kelly D. Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 169: 610-7. PMID 8932891 DOI: 10.1192/Bjp.169.5.610  0.423
1996 Javitt DC. Glycine therapy of schizophrenia. Biological Psychiatry. 40: 684-6. PMID 8886307 DOI: 10.1016/0006-3223(96)00269-7  0.43
1996 Javitt DC, Steinschneider M, Schroeder CE, Arezzo JC. Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 93: 11962-7. PMID 8876245 DOI: 10.1073/Pnas.93.21.11962  0.337
1996 Leiderman E, Zylberman I, Zukin SR, Cooper TB, Javitt DC. Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial. Biological Psychiatry. 39: 213-5. PMID 8837983 DOI: 10.1016/0006-3223(95)00585-4  0.404
1996 Shelley AM, Grochowski S, Lieberman JA, Javitt DC. Premature disinhibition of P3 generation in schizophrenia. Biological Psychiatry. 39: 714-9. PMID 8731459 DOI: 10.1016/0006-3223(95)00222-7  0.438
1996 Umbricht D, Novak G, Bilder R, Javitt D, Bates J, Pollack S, Lieberman J, Kane J. Electrophysiology and sleep Event-related potentialsDeficits in generation of auditory event-related potentials, neuropsychological performance and psychopathology in chronic schizophrenia Schizophrenia Research. 18: 232. DOI: 10.1016/0920-9964(96)85712-4  0.391
1996 Shelley A, Javitt D, Vaughan H. Mechanisms of auditory working memory dysfunction in schizophrenia Biological Psychiatry. 39: 655. DOI: 10.1016/0006-3223(96)84464-7  0.432
1996 Cienfiuegos A, March L, Shelley A, Javitt D. Abnormal categorical perception of simple speech sounds in schizophrenia Biological Psychiatry. 39: 576. DOI: 10.1016/0006-3223(96)84208-9  0.457
1996 Javitt D, Shelley A, Leiderman E, March L, Cowan N, Ritter W. ERP and behavioral indices of working memory dysfunction in schizophrenia Biological Psychiatry. 39: 565. DOI: 10.1016/0006-3223(96)84172-2  0.407
1995 Zylberman I, Javitt DC, Zukin SR. Pharmacological augmentation of NMDA receptor function for treatment of schizophrenia. Annals of the New York Academy of Sciences. 757: 487-91. PMID 7611706 DOI: 10.1111/j.1749-6632.1995.tb17508.x  0.406
1995 Javitt DC, Doneshka P, Grochowski S, Ritter W. Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia. Archives of General Psychiatry. 52: 550-8. PMID 7598631 DOI: 10.1001/archpsyc.1995.03950190032005  0.512
1995 Strous RD, Cowan N, Ritter W, Javitt DC. Auditory sensory ("echoic") memory dysfunction in schizophrenia. The American Journal of Psychiatry. 152: 1517-9. PMID 7573594 DOI: 10.1176/Ajp.152.10.1517  0.445
1995 Umbricht D, Novak G, Bilder R, Javitt D, Pollack S, Lieberman J, Kane J. Mismatch negativity, neuropsychological deficits and psychopathology in chronic schizophrenia Schizophrenia Research. 15: 187-188. DOI: 10.1016/0920-9964(95)95577-V  0.482
1995 Shelley A, Grochowski S, Lieberman J, Javitt D. Visual working-memory dysfunction and P3 in schizophrenia Schizophrenia Research. 15: 185. DOI: 10.1016/0920-9964(95)95570-Y  0.433
1995 Javitt D, Shelley A, Grochowski S, Lieberman J. Mismatch negativity (MMN) in first episodic and chronic schizophrenic subjects Schizophrenia Research. 15: 179. DOI: 10.1016/0920-9964(95)95552-K  0.309
1995 Javitt D, Steinschneider M, Schroeder C, Arezzo J. Intracortical mechanisms underlying mismatch negativity (MMN) generation in monkeys: Implications for working memory and the PCP/NMDA model of schizophrenia Schizophrenia Research. 15: 179. DOI: 10.1016/0920-9964(95)95551-J  0.413
1995 Javitt D, Shelley A, Grochowski S, Ritter W. Mismatch negativity (MMN) as an index of impaired auditory sensory memory in schizophrenia Schizophrenia Research. 15: 179. DOI: 10.1016/0920-9964(95)95550-S  0.467
1995 Zylberman I, Javitt D, Zukin S. NMDA receptor augmentation therapy in schizophrenia Schizophrenia Research. 15: 171. DOI: 10.1016/0920-9964(95)95530-M  0.388
1995 Strous R, Grochowski S, Cowan N, Javitt D. Dysfunctional encoding of auditory information in schizophrenia Schizophrenia Research. 15: 135. DOI: 10.1016/0920-9964(95)95420-E  0.479
1994 Javitt DC, Zylberman I, Zukin SR, Heresco-Levy U, Lindenmayer JP. Amelioration of negative symptoms in schizophrenia by glycine. The American Journal of Psychiatry. 151: 1234-6. PMID 8037263 DOI: 10.1176/Ajp.151.8.1234  0.415
1994 Shelley A, Javitt D, Lieberman J, Grochowski S. Premature disinhibition of visual P3 in schizophrenia Biological Psychiatry. 35: 673-674. DOI: 10.1016/0006-3223(94)90869-9  0.475
1994 Strous R, Javitt D, Grochowski S, Shelley A. Impaired auditory sensory (“Echoic”) memory in schizophrenia Biological Psychiatry. 35: 636. DOI: 10.1016/0006-3223(94)90737-4  0.462
1994 Javitt D, Shelley A, Grochowski S, Ritter W. Impaired cognitive processing within 1° auditory cortex in schizophrenia Biological Psychiatry. 35: 615. DOI: 10.1016/0006-3223(94)90660-2  0.483
1993 Javitt DC, Doneshka P, Zylberman I, Ritter W, Vaughan HG. Impairment of early cortical processing in schizophrenia: an event-related potential confirmation study. Biological Psychiatry. 33: 513-9. PMID 8513035 DOI: 10.1016/0006-3223(93)90005-X  0.521
1993 Winsberg BG, Javitt DC, Silipo GS, Doneshka P. Mismatch negativity in hyperactive children: effects of methylphenidate. Psychopharmacology Bulletin. 29: 229-33. PMID 8290670 DOI: 10.1097/00002826-199202001-01120  0.331
1993 Heresco-Levy U, Javitt DC, Zukin SR. The Phencyclidine/N-Methyl-D-Aspartate (PCP/ NMDA) Model of Schizophrenia: Theoretical and Clinical Implications Psychiatric Annals. 23: 135-143. DOI: 10.3928/0048-5713-19930301-09  0.385
1992 Javitt DC, Schroeder CE, Steinschneider M, Arezzo JC, Vaughan HG. Demonstration of mismatch negativity in the monkey. Electroencephalography and Clinical Neurophysiology. 83: 87-90. PMID 1376671 DOI: 10.1016/0013-4694(92)90137-7  0.365
1992 Steinschneider M, Tenke CE, Schroeder CE, Javitt DC, Simpson GV, Arezzo JC, Vaughan HG. Cellular generators of the cortical auditory evoked potential initial component. Electroencephalography and Clinical Neurophysiology. 84: 196-200. PMID 1372236 DOI: 10.1016/0168-5597(92)90026-8  0.321
1991 Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. The American Journal of Psychiatry. 148: 1301-8. PMID 1654746 DOI: 10.1176/Ajp.148.10.1301  0.464
1987 Javitt DC. Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. The Hillside Journal of Clinical Psychiatry. 9: 12-35. PMID 2820854  0.364
Low-probability matches (unlikely to be authored by this person)
1996 Umbricht D, Novak G, Javitt D, Pollack S, Lieberman J, Kane J. The effects of clozapine treatment on auditory event-related potentials (aERP) Biological Psychiatry. 39: 652-653. DOI: 10.1016/0006-3223(96)84457-X  0.299
2019 Bodkin JA, Coleman MJ, Godfrey LJ, Carvalho CMB, Morgan CJ, Suckow RF, Anderson T, Ongur D, Kaufman MJ, Lewandowski KE, Siegel AJ, Waldstreicher E, Grochowski CM, Javitt DC, Rujescu D, et al. Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene. Biological Psychiatry. PMID 31279534 DOI: 10.1016/J.Biopsych.2019.04.031  0.298
1998 Heresco-Levy U, Javitt DC. The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 8: 141-52. PMID 9619693 DOI: 10.1016/S0924-977X(97)00050-3  0.298
2019 Moreno-Ortega M, Prudic J, Rowny S, Patel GH, Kangarlu A, Lee S, Grinband J, Palomo T, Perera T, Glasser MF, Javitt DC. Resting state functional connectivity predictors of treatment response to electroconvulsive therapy in depression. Scientific Reports. 9: 5071. PMID 30911075 DOI: 10.1038/S41598-019-41175-4  0.298
2021 Sehatpour P, Javitt DC, De Baun HM, Carlson M, Beloborodova A, Margolin DH, Carlton MBL, Brice NL, Kantrowitz JT. Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 34667294 DOI: 10.1038/s41386-021-01170-8  0.297
2012 Chouake T, Levy T, Javitt DC, Lavidor M. Magnocellular training improves visual word recognition. Frontiers in Human Neuroscience. 6: 14. PMID 22363277 DOI: 10.3389/fnhum.2012.00014  0.297
2000 Deacon D, Gomes H, Nousak JM, Ritter W, Javitt D. Effect of frequency separation and stimulus rate on the mismatch negativity: an examination of the issue of refractoriness in humans. Neuroscience Letters. 287: 167-70. PMID 10863021 DOI: 10.1016/S0304-3940(00)01175-7  0.296
2001 Balla A, Hashim A, Burch S, Javitt DC, Lajtha A, Sershen H. Phencyclidine-induced dysregulation of dopamine response to amphetamine in prefrontal cortex and striatum. Neurochemical Research. 26: 1001-6. PMID 11699927 DOI: 10.1023/A:1012396820510  0.294
2001 Shoham S, Javitt DC, Heresco-Levy U. Chronic high-dose glycine nutrition: effects on rat brain cell morphology. Biological Psychiatry. 49: 876-85. PMID 11343684 DOI: 10.1016/S0006-3223(00)01046-5  0.293
1997 Schroeder CE, Javitt DC, Steinschneider M, Mehta AD, Givre SJ, Vaughan HG, Arezzo JC. N-methyl-D-aspartate enhancement of phasic responses in primate neocortex. Experimental Brain Research. 114: 271-8. PMID 9166916 DOI: 10.1007/Pl00005635  0.292
2003 Dias E, Silipo G, Javitt D. AX-CPT performance in schizophrenics varies with cue complexity Schizophrenia Research. 60: 167. DOI: 10.1016/S0920-9964(03)81028-9  0.291
1996 Heresco-Levy U, Silipo G, Javitt DC. Glycinergic augmentation of NMDA receptor-mediated neurotransmission in the treatment of schizophrenia. Psychopharmacology Bulletin. 32: 731-40. PMID 8993096  0.291
1999 Shoham S, Javitt DC, Heresco-Levy U. High dose glycine nutrition affects glial cell morphology in rat hippocampus and cerebellum. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 2: 35-40. PMID 11281969 DOI: 10.1017/S1461145799001285  0.29
2017 Moreno-Ortega M, Rowny S, Prudic J, Kangarlu A, Lee S, Patel G, Grinband J, Javitt D. Differential coupling of the dorsolateral prefrontal cortex with default network and visual cortex in patients recovered from depression after convulsive therapy Brain Stimulation. 10: e31. DOI: 10.1016/J.Brs.2017.04.041  0.289
2019 Rakovska A, Javitt D, Petkova-Kirova P, Balla A, Ang R, Kalfin R. Neurochemical evidence that cysteamine modulates amphetamine-induced dopaminergic neuronal activity in striatum by decreasing dopamine release: an in vivo microdialysis study in freely moving rats. Brain Research Bulletin. PMID 31401065 DOI: 10.1016/j.brainresbull.2019.08.005  0.288
1995 Javitt DC, Schroeder CE, Steinschneider M, Arezzo JC, Ritter W, Vaughan HG. Cognitive event-related potentials in human and non-human primates: implications for the PCP/NMDA model of schizophrenia. Electroencephalography and Clinical Neurophysiology. Supplement. 44: 161-75. PMID 7649018  0.287
2005 Javitt DC, Duncan L, Balla A, Sershen H. Inhibition of system A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action. Molecular Psychiatry. 10: 275-87. PMID 15278098 DOI: 10.1038/sj.mp.4001552  0.284
2018 Delaney S, Fallon B, Alaedini A, Yolken R, Indart A, Feng T, Wang Y, Javitt D. Inflammatory biomarkers in psychosis and clinical high risk populations. Schizophrenia Research. PMID 30414721 DOI: 10.1016/J.Schres.2018.10.017  0.284
1996 Umbricht D, Novak G, Javitt D, Pollack S, Lieberman J, Kane J. The effect of clozapine treatment on mismatch negativity Schizophrenia Research. 18: 222. DOI: 10.1016/0920-9964(96)85682-9  0.276
1996 Strous RD, Javitt DC. The N-methyl-D-aspartate receptor and schizophrenia. Israel Journal of Medical Sciences. 32: 275-81. PMID 8641863  0.275
1995 Umbricht D, Novak G, Bilder R, Javitt D, Pollock S, Lieberman J, Kane J. Mismatch negativity during treatment with clozapine Schizophrenia Research. 15: 187. DOI: 10.1016/0920-9964(95)95576-U  0.275
2023 Medalia A, Saperstein A, Javitt DC, Qian M, Meyler S, Styke S. Feasibility and clinical utility of using the tone matching test for assessment of early auditory processing in schizophrenia. Psychiatry Research. 323: 115152. PMID 36907004 DOI: 10.1016/j.psychres.2023.115152  0.274
2005 Lakatos P, Pincze Z, Fu KM, Javitt DC, Karmos G, Schroeder CE. Timing of pure tone and noise-evoked responses in macaque auditory cortex. Neuroreport. 16: 933-7. PMID 15931064 DOI: 10.1097/00001756-200506210-00011  0.268
2006 Javitt DC. Glutamate involvement in schizophrenia: Focus on N-methyl-D-aspartate receptors Primary Psychiatry. 13: 38-46.  0.262
1994 Javitt DC, Steinschneider M, Schroeder CE, Vaughan HG, Arezzo JC. Detection of stimulus deviance within primate primary auditory cortex: intracortical mechanisms of mismatch negativity (MMN) generation. Brain Research. 667: 192-200. PMID 7697356 DOI: 10.1016/0006-8993(94)91496-6  0.257
2008 Bickel S, Dias EC, Saccente E, Sehatpour P, Javitt DC. ELECTROPHYSIOLOGICAL ACTIVITY RELATED TO MOTOR PREPARATION AND EXECUTIVE CONTROL IN THE AX-CPT TASK Schizophrenia Research. 102: 110. DOI: 10.1016/S0920-9964(08)70333-5  0.256
2013 Heresco-Levy U, Gelfin G, Bloch B, Levin R, Edelman S, Javitt DC, Kremer I. A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 501-6. PMID 23174090 DOI: 10.1017/S1461145712000910  0.254
2014 Javitt DC, Liu J, Liu MT, Maroney M, Mathis AS. Participating faculty: Balancing therapeutic safety and efficacy to improve clinical and economic outcomes in schizophrenia [CME/CPE] American Journal of Managed Care. 20.  0.253
2023 Christofalos AL, Laks M, Wolfer S, Dias EC, Javitt DC, Sheridan H. EXPRESS: Lower-level oculomotor deficits in schizophrenia during multi-line reading: Evidence from return-sweeps. Quarterly Journal of Experimental Psychology (2006). 17470218231220752. PMID 38053311 DOI: 10.1177/17470218231220752  0.252
2019 Kantrowitz J, Ivgy-May N, Morikawa K, Marcy B, Yoshida S, Kegeles L, Grinband J, Girgis R, Wall M, Choo T, Horga G, Javitt D, Lieberman J. F181. A Randomized, Single-Blind, Parallel-Group Study to Evaluate the Effects of TS-134 on Ketamine- Induced Bold Signals in Resting fMRI in Healthy Adult Subjects Biological Psychiatry. 85: S283-S284. DOI: 10.1016/J.Biopsych.2019.03.718  0.252
2013 Javitt DC. Harnessing N-methyl-d-aspartate receptors for new treatment development in psychiatry: positive lessons from negative studies. The American Journal of Psychiatry. 170: 699-702. PMID 23820828 DOI: 10.1176/appi.ajp.2013.13040503  0.249
2014 Rohrig S, Adair D, Kaszowska A, Sehatpour P, Javitt DC. Modulating Effects of Transcranial Direct Current Stimulation on Event Related Potentials in a Motor Sequence Task Brain Stimulation. 7: e7. DOI: 10.1016/j.brs.2014.01.028  0.248
1989 Javitt DC, Zukin SR. Interaction of [3H]MK-801 with multiple states of the N-methyl-D-aspartate receptor complex of rat brain. Proceedings of the National Academy of Sciences of the United States of America. 86: 740-4. PMID 2536176 DOI: 10.1073/Pnas.86.2.740  0.245
2004 Javitt D. S.08.04 Amino acid transporters as therapeutic targets in schizophrenia European Neuropsychopharmacology. 14: S129-S130. DOI: 10.1016/S0924-977X(04)80031-2  0.245
2014 Javitt DC. Balancing therapeutic safety and efficacy to improve clinical and economic outcomes in schizophrenia: exploring the treatment landscape. The American Journal of Managed Care. 20: S166-73. PMID 25180706  0.244
2009 Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA, Andreasen NC, Brady KT, Brent DA, Brzustowicz L, Carter CS, Eisenberg L, Goldman H, Javitt DC, Leibenluft E, et al. Conflict of interest-- an issue for every psychiatrist. The American Journal of Psychiatry. 166: 274. PMID 19255048 DOI: 10.1176/Appi.Ajp.2009.09010093  0.243
2000 Bruder G, Javitt D, McCarley R, Turetsky B. 11. New directions in cortical electrophysiology: from basic neuroscience to clinical research Biological Psychiatry. 47: S4. DOI: 10.1016/S0006-3223(00)00263-8  0.241
2017 Sehatpour P, Adair D, Rohrig S, DiCostanzo J, Javitt DC. Transcranial Direct Current Stimulation Modulates Cortical Networks Brain Stimulation. 10: e7. DOI: 10.1016/j.brs.2016.11.040  0.239
2013 Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA, Gabbard GO, Gau SS, Javitt DC, Oquendo MA, Shrout PE, Vieta E, Yager J. The initial field trials of DSM-5: new blooms and old thorns. The American Journal of Psychiatry. 170: 1-5. PMID 23288382 DOI: 10.1176/Appi.Ajp.2012.12091189  0.237
1987 Javitt DC, Jotkowitz A, Sircar R, Zukin SR. Non-competitive regulation of phencyclidine/sigma-receptors by the N-methyl-D-aspartate receptor antagonist D-(-)-2-amino-5-phosphonovaleric acid. Neuroscience Letters. 78: 193-8. PMID 2888059 DOI: 10.1016/0304-3940(87)90632-X  0.236
1994 Heresco-Levy U, Lerer B, Greenberg D, Javitt D, Brown W. Serum levels of fluphenazine in schizophrenic outpatients maintained on two reduced doses of fluphenazine decanoate European Neuropsychopharmacology. 4: 385-386. DOI: 10.1016/0924-977X(94)90214-3  0.235
1991 Nussenzveig IZ, Sircar R, Wong ML, Frusciante MJ, Javitt DC, Zukin SR. Polyamine effects upon N-methyl-D-aspartate receptor functioning: differential alteration by glutamate and glycine site antagonists. Brain Research. 561: 285-91. PMID 1686987 DOI: 10.1016/0006-8993(91)91606-2  0.233
1995 Ritter W, Deacon D, Gomes H, Javitt DC, Vaughan HG. The mismatch negativity of event-related potentials as a probe of transient auditory memory: a review. Ear and Hearing. 16: 52-67. PMID 7774769 DOI: 10.1097/00003446-199502000-00005  0.232
2014 Javitt DC. Balancing therapeutic safety and efficacy to improve clinical and economic outcomes in schizophrenia: a clinical overview. The American Journal of Managed Care. 20: S160-5. PMID 25180705  0.226
2017 Delaney S, Javitt D, Fallon B, Alaedini A, Yolken R, Feng T, Wang Y. 306. Inflammatory Biomarkers in Psychosis Biological Psychiatry. 81: S126. DOI: 10.1016/J.Biopsych.2017.02.321  0.223
2009 Heresco-Levy U, Javitt DC, Gelfin Y, Kaufman Y, Levin R, Korn-Lubetzki I, Bloch B, Wolosker H, Kremer I. P.1.c.008 D-serine adjuvant treatment alleviates motor and behavioural symptoms in idiopathic Parkinson's disease European Neuropsychopharmacology. 19. DOI: 10.1016/S0924-977X(09)70368-2  0.221
2002 Javitt DC, Balla A, Sershen H. A novel alanine-insensitive D-serine transporter in rat brain synaptosomal membranes. Brain Research. 941: 146-9. PMID 12031557 DOI: 10.1016/S0006-8993(02)02557-X  0.22
2008 Javitt D. GLUTAMATE IS SENSATIONAL. THINK ABOUT IT! Schizophrenia Research. 102: 7. DOI: 10.1016/S0920-9964(08)70022-7  0.215
2010 Javitt DC. EFFECTS OF INTRANASAL AL-108 (DAVUNETIDE) ON NEUROCOGNITION AND FUNCTIONAL OUTCOME IN SCHIZOPHERENIA Schizophrenia Research. 117: 118-119. DOI: 10.1016/j.schres.2010.02.052  0.21
2004 Javitt DC. Glutamate receptors as therapeutic targets Molecular Psychiatry. 9: 979. DOI: 10.1038/sj.mp.4001602  0.208
2015 Yee CM, Javitt DC, Miller GA. Replacing DSM Categorical Analyses With Dimensional Analyses in Psychiatry Research: The Research Domain Criteria Initiative. Jama Psychiatry. 1159-1160. PMID 26559005 DOI: 10.1001/jamapsychiatry.2015.1900  0.2
2003 Rakovska A, Javitt D, Raichev P, Ang R, Balla A, Aspromonte J, Vizi S. Physiological release of striatal acetylcholine (in vivo): effect of somatostatin on dopaminergic-cholinergic interaction. Brain Research Bulletin. 61: 529-36. PMID 13679252 DOI: 10.1016/S0361-9230(03)00192-8  0.197
2004 Xie S, Aspromonte J, Balla A, Sershen H, Javitt DC, Cooper TB. Sensitive and simple gas chromatographic-mass spectrometric determination for amphetamine in microdialysate and ultrafiltrate samples. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 805: 27-31. PMID 15113536 DOI: 10.1016/j.jchromb.2004.02.001  0.194
2007 Revheim N, Javitt DC. Reading disability goes beyond consent forms. Psychiatric Services (Washington, D.C.). 58: 566. PMID 17412864 DOI: 10.1176/Appi.Ps.58.4.566  0.185
2000 Smiley JF, McGinnis JP, Javitt DC. Nitric oxide synthase interneurons in the monkey cerebral cortex are subsets of the somatostatin, neuropeptide Y, and calbindin cells. Brain Research. 863: 205-12. PMID 10773208 DOI: 10.1016/S0006-8993(00)02136-3  0.184
2002 BUTLER PD, SCHECHTER I, ZEMON V, SCHWARTZ SG, GREENSTEIN VC, GORDON J, SCHROEDER CE, JAVITT DC. Dr. Butler and Colleagues Reply American Journal of Psychiatry. 159: 678-a-679. DOI: 10.1176/Appi.Ajp.159.4.678-A  0.178
2006 Zukin SR, Javitt DC. Dr. Zukin and Dr. Javitt Reply American Journal of Psychiatry. DOI: 10.1176/Ajp.149.6.849  0.173
1990 Javitt DC, Zukin SR. The role of excitatory amino acids in neuropsychiatric illness. The Journal of Neuropsychiatry and Clinical Neurosciences. 2: 44-52. PMID 1983773  0.166
1995 Schroeder CE, Steinschneider M, Javitt DC, Tenke CE, Givre SJ, Mehta AD, Simpson GV, Arezzo JC, Vaughan HG. Localization of ERP generators and identification of underlying neural processes. Electroencephalography and Clinical Neurophysiology. Supplement. 44: 55-75. PMID 7649056  0.165
2020 Sehatpour P, Dondé C, Adair D, Kreither J, Lopez-Calderon J, Avissar M, Bikson M, Javitt DC. Comparison of cortical network effects of high-definition and conventional tDCS during visuomotor processing. Brain Stimulation. PMID 33181350 DOI: 10.1016/j.brs.2020.11.004  0.136
2015 Bedi G, Carrillo F, Cecchi GA, Slezak DF, Sigman M, Mota NB, Ribeiro S, Javitt DC, Copelli M, Corcoran CM. Automated analysis of free speech predicts psychosis onset in high-risk youths. Npj Schizophrenia. 1: 15030. PMID 27336038 DOI: 10.1038/npjschz.2015.30  0.134
1997 Heresco-Levy U, Greenberg D, Lerer B, Javitt DC, Brown WA. Serum neuroleptic levels during reduced dose fluphenazine decanoate maintenance therapy. The Israel Journal of Psychiatry and Related Sciences. 34: 281-9. PMID 9409085  0.13
2002 Heresco-Levy U, Kremer I, Javitt DC, Goichman R, Reshef A, Blanaru M, Cohen T. Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 5: 301-7. PMID 12466030 DOI: 10.1017/S1461145702003061  0.12
1996 Negrón AE, Leiderman EA, Parkadavil M, Cienfuegos A, Javitt DC. A naturalistic outcome study of risperidone treatment among hospital patients. Psychiatric Services (Washington, D.C.). 47: 1118-20. PMID 8890343  0.113
2021 Kantrowitz JT, Dong Z, Milak MS, Rashid R, Kegeles LS, Javitt DC, Lieberman JA, John Mann J. Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder. Translational Psychiatry. 11: 419. PMID 34354048 DOI: 10.1038/s41398-021-01541-1  0.106
2023 Nierenberg A, Lavin P, Javitt DC, Shelton R, Sapko MT, Mathew S, Besthof RE, Javitt JC. NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial. International Journal of Bipolar Disorders. 11: 28. PMID 37573534 DOI: 10.1186/s40345-023-00308-5  0.106
1989 Javitt D. Mechanisms and Therapeutic Implications of Neuroleptic Atypicality Jefferson Journal of Psychiatry. 7. DOI: 10.29046/JJP.007.1.001  0.095
1990 Javitt DC, Frusciante MJ, Zukin SR. Rat brain N-methyl-D-aspartate receptors require multiple molecules of agonist for activation. Molecular Pharmacology. 37: 603-7. PMID 2160056  0.091
1994 Javitt DC, Frusciante MJ, Zukin SR. Activation-related and activation-independent effects of polyamines on phencyclidine receptor binding within the N-methyl-D-aspartate receptor complex. The Journal of Pharmacology and Experimental Therapeutics. 270: 604-13. PMID 7915316  0.087
1989 Javitt DC, Zukin SR. Biexponential kinetics of [3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels. Molecular Pharmacology. 35: 387-93. PMID 2468076  0.083
1989 Zukin SR, Javitt DC. Mechanisms of phencyclidine (PCP)-n-methyl-d-aspartate (NMDA) receptor interaction: implications for drug abuse research. Nida Research Monograph. 95: 247-54. PMID 2561829  0.077
1988 Javitt DC, Weinstein SL, Opler LA. The possible role of dopamine autoreceptors in neuroleptic atypicality. Psychiatric Developments. 6: 57-71. PMID 2902622  0.075
1993 Zukin SR, Javitt DC. Phencyclidine receptor binding as a probe of NMDA receptor functioning: implications for drug abuse research. Nida Research Monograph. 133: 1-12. PMID 8232509  0.052
2011 Javitt D. S.28.03 Glycine transport inhibitors for the treatment of psychiatric disorders European Neuropsychopharmacology. 21: S230-S231. DOI: 10.1016/S0924-977X(11)70354-6  0.05
2008 Javitt DC, First MB. Substance Abuse: Phencyclidine Use Disorders Psychiatry: Third Edition. 1: 1090-1099. DOI: 10.1002/9780470515167.ch59  0.04
1988 Javitt DC, Zukin SR. Modulation of phencyclidine receptors by excitatory amino acid receptor ligands. Psychopharmacology Bulletin. 24: 444-9. PMID 2856419  0.034
2011 Kantrowitz JT, Javitt DC. The authors respond Current Psychiatry. 10: 4.  0.034
1989 Sircar R, Frusciante MJ, Javitt DC, Zukin SR. Glycine reverses 7-chlorokynurenic acid-induced inhibition of [3H]MK-801 binding. Brain Research. 504: 325-7. PMID 2557130 DOI: 10.1016/0006-8993(89)91378-4  0.026
2008 Chao M, Flint J, Talmage DA, Bothwell M, Buonanno A, Lu B, Akil H, Malaspina D, Raff MC, Castrén E, Javitt DC, Owen MJ, Giedd JN, Sklar P. General discussion I Novartis Foundation Symposium. 289: 87-93.  0.013
2021 Javitt DC. Translational Mechanistic Biomarkers for the 21st Century. The American Journal of Psychiatry. 178: 893-895. PMID 34592844 DOI: 10.1176/appi.ajp.2021.21080812  0.01
2008 Chao M, Javitt DC, Raff MC, Lu B, Barde YA, Flint J, Owen MJ, Malaspina D, Tongiorgi E, Buonanno A. Discussion Novartis Foundation Symposium. 289: 17-22.  0.01
2000 Javitt DC, Heresco-Levy U. Are glycine sites saturated in vivo? Archives of General Psychiatry. 57: 1181-3. PMID 11115334  0.01
Hide low-probability matches.